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Abstract
Aims
This study examines the clinical and molecular genetic features o f X-linked Congenital 
Stationary Night Blindness (XLCSNB). The aims are to accurately document the 
phenotype o f affected subjects by investigating functional visual deficit, to evaluate 
possible disease mechanisms and to confirm or refute the veracity o f the “complete” and 
“incomplete” descriptions of phenotype in common clinical usage. In addition, by 
identifying causative gene mutations in the pedigrees studied, the study investigates the 
possibility o f a genotype-phenotype correlation.
Methods
Members o f fifteen families previously diagnosed as having XLCSNB underwent 
standardised clinical, psychophysical and electrophysiological phenotypic testing. 
Comprehensive mutation screening of the genes N YX  and CACNA1F was performed for 
each pedigree.
Results
Seven different loss-of-function mutations in the N YX  gene were identified in 11 families 
and three mutations in the CACNA1F gene were identified in another three pedigrees. No 
mutations w ere detected in members of the remaining pedigree and this family was 
excluded from further study. Electrophysiological and psychophysical evidence of a 
functioning but impaired rod system was present in subjects from each genotype group, 
although scotopic responses tended to be more severely affected in subjects with NYX  
gene mutations. Scotopic oscillator)’ potentials were absent in all subjects with NYX  gene 
mutations whilst subnormal OFF responses were specific to subjects with CACNA1F gene 
mutations.
Conclusions
N YX  gene mutations were a more frequent cause of XLCSNB than CACNA IF  gene 
mutations in the 15 British families studied. Since evidence of a functioning rod system 
was identified in the majority of subjects tested, the clinical phenotypes “complete” and 
“incomplete” do not correlate with genotype. Instead, electrophysiological indicators of 
inner retinal function, specifically the characteristics o f scotopic oscillatory potentials, 
30Hz flicker and the OFF response may prove more discriminatory.
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Chapter 1 Introduction
1.1 Aetiology of nyctalopia (night blindness)
Nyctalopia, or night blindness, is a common symptom, which may result from 
dysfunction o f rod photoreceptors or their inner retinal connections. Nyctalopia may 
progress in severity or remain stationary throughout life. Progressive night blindness in 
association with visual field loss and abnormal ophthalmoscopic retinal appearance may 
result from inherited disorders of the outer retina such as retinitis pigmentosa and 
choroideraemia. or choroidal dystrophies such as gyrate atrophy. Acquired progressive 
night blindness due to vitamin A deficiency is a common result of malnutrition in 
developing countries and may also be seen as a complication of malabsorption secondary 
to gastro-intestinal disease in the UK. Acquired night blindness may also rarely occur as 
a manifestation of distant cancer, particularly cutaneous malignant melanoma.
1.2 Congenital stationary night blindness -historical review
The retinal dystrophy of congenital stationary night blindness (CSNB) was first reported 
by Cunier (Cunier 1838). He described a condition characterized by congenital non­
progressive nyctalopia in members o f a seven generation dominant pedigree (the 
Nougaret family) in Southern France. Affected individuals in this pedigree had good 
visual acuity and colour vision with a normal fundoscopic appearance. More recently this 
pedigree, now comprising eleven generations, has been investigated by Nettleship and 
DeJean and. soon after Cunier's description of autosomal dominant CSNB (ADCSNB). 
X-linked and autosomal recessive pedigrees were also identified (Nettleship 1907. 
Donders 1855: Varelmann 1925).
In 1907. Oguchi described an unusual form of CSNB characterized by an abnormal 
discolouration of the retina, giving a metallic-looking sheen to the fundus. This form of 
CSNB was subsequently named Oguchi disease (Oguchi 1907).
Lauber reported another form of congenital nyctalopia in 1910. This condition was 
named fundus albipunctatus for the characteristic multitude of small yellow-white spots
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visible in the peri-macular and peripheral retina on fundoscopv (Lauber 1910; 
Franceschetti and Chrome-Brecioux 1951).
Flecked retina o f Kandori was reported as a distinct entity in 1958. since the initial report 
an additional three affected individuals have been identified (Kandori 1959). Flecked 
retina o f Kandori may be distinguished from the other forms o f CSNB by the presence of 
variably sized, irregular yellow flecks which are larger than those seen in fundus 
albipunctatus and which occur in the equatorial region but spare the peri-macular retina.
1.3 Classification of congenital stationary night blindness
Following these reports CSNB was classified on the basis of its clinical features and 
inheritance.
1 CSNB with abnormal fundi
Oguchi disease (autosomal recessive)
Fundus albipunctatus (autosomal recessive)
Flecked retina o f Kandori (autosomal recessive)
II CSNB with normal fundi
Autosomal dominant (Nougaret variety)
Autosomal recessive
X-linked recessive
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1.4 CSNB with abnormal fundus appearance
1.4.1 Oguchi d isease
1.4.1..1 Clinical features
Individuals with Oguchi disease are commonly o f Asian ancestry and complain of night 
blindness but have normal visual acuity, visual fields and colour vision. The 
characteristic feature of this condition is the retinal appearance on fundoscopy. In light 
adapted conditions a golden-brown tapetal reflex is visible, on dark adaptation this reflex 
fades and the fundus appearance becomes normal (Mizuo 1913). This fundoscopic 
phenomenon (the Mizuo-Nakamura phenomenon) has also been documented in some 
individuals with X-linked retinoschisis and X-linked cone dystrophy (Mizuo 1913; 
Noble. Margolis et al. 1989; de Jong. Zrenner et al. 1991). To date two genes have been 
found to be responsible for Oguchi disease, both are involved in the recovery phase o f 
the phototransduction mechanism: the gene SAG encodes the protein arrestin and RHOK 
encodes rhodopsin kinase (Table 1) (Fuchs et al. 1995; Yamamoto et al. 1997).
1.4.1..2 Electrophysiological and psychophysical testing
The rod pathway responses are unrecordable in Oguchi disease. Although early 
electrophysiological studies indicated that the b-wave amplitude alone was subnormal in 
the electroretinogram (ERG), more recent studies o f subjects with SAG  gene mutations 
have demonstrated subnormal a- and b-wave amplitudes indicating that rod 
phototransduction is abnormal in this condition (Carr and Ripps 1967;Nakazawa et al. 
1997). Cone pathway response amplitudes are within the normal range. Dark adaptation 
is characteristically slow and a final rod threshold may only be achieved after several 
hours, and even then may be slightly elevated (Nakazawa. Wada et al. 1997).
1.4.2 Fundus albipunctatus
1.4.2..1 Clinical features
Individuals with fundus albipunctatus (FA) are night blind but have good visual acuity, 
visual fields and colour vision (Margolis, Siegel et al. 1987). This form of congenital 
stationary night blindness is characterised by the presence of small vellow-white flecks 
in the retina peripheral to the macula. These flecks appear to lie in the deep retina and
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become more numerous and punctate with age (Marmor 1990). Studies of rhodopsin 
kinetics have confirmed that the condition is associated with a delay in rhodopsin 
regeneration (Ripps 1982). FA results from loss-of-function mutations in the gene 
RDH5, which encodes the protein 1 \-cis retinol dehydrogenase. This results in markedly 
reduced conversion of 11-cA retinol to 11 -cis retinal in the retinal pigment epithelium, 
thereby slowing rhodopsin regeneration (Yamamoto and Simon 1999).
1.4.2..2 Electrophysiological and psychophysical testing
In most cases, rod and cone dark adaptation are markedly prolonged and there is a delay 
in the acquisition o f scotopic ERG thresholds but near normal photopic responses 
(Marmor 1977; Margolis. Siegel et al. 1987). Variations have been reported in which the 
dark adaptation curves and ERG are normal or dark adaptation shows a cone segment 
only (Franceschetti and Chrome-Brecioux 1951). These variations may either represent 
various degrees of severity of a single disorder or several separate disorders with a 
similar fundus appearance.
1.4.3 Flecked retina of Kandori
1.4.3..1 Clinical features
This is a rare condition which has only been described in Japanese individuals. It causes 
mild nyctalopia but the visual acuity, colour vision and visual field examination are 
normal. The distinguishing feature of this condition is the presence of large (up to 1.5 
disc diameters) sharply defined, dark yellow, deep and irregular flecks, which are 
distributed in the equatorial region of the fundus, sparing the macula.
1.4.3..2 Electrophysiological and psychophysical testing
The cone mediated ERG is normal but prolonged dark adaptation is required before the 
rod mediated responses are recordable. Dark adaptometry shows initial delay in the 
recover}' o f rod sensitivity but attainment of normal thresholds within 40 minutes 
(Kandori. Tamai et al. 1972).
Chapter 1; Introduction 1-15
A Clinical and Molecular Genetic Investigation of XLCSNB LE Allen
1.5 CSNB with normal fundus appearance
This is the most common form of CSNB but is probably under diagnosed due to the 
paucity of symptoms and ocular findings. This form o f CSNB is genetically 
heterogeneous; although X-linked recessive transmission is the most common 
inheritance pattern, autosomal dominant and autosomal recessive transmission may also 
occur. Recent molecular genetic investigation of ADCSNB and X-linked recessive 
CSNB (XLCSNB) has led to the identification o f causative gene mutations and improved 
understanding of the molecular pathophysiological basis o f these forms o f nyctalopia 
(see Chapter 4). CSNB is clinically heterogeneous: in general, autosomal dominant 
inheritance is associated with mild nyctalopia and good visual acuity while the recessive 
forms of CSNB tend to cause more severe night blindness and are often associated with 
reduced visual acuity, nystagmus, strabismus and myopia (see Chapter 3).
A clinical classification based on the psychophysical and electrophysiological 
differences between individuals and families with recessivelv inherited CSNB is widely 
used. This sub-classification is based on the ability to detect a scotopic or rod mediated 
response on electrophysiological or psychophysical testing. Subjects in whom no 
detectable rod mediated response is evident are classified as having “complete" CSNB. 
those with a subnormal but recordable rod mediated response are classified as having the 
“incomplete" form (Miyake. Yagasaki et al. 1986). It has been thought that these two 
phenotypic forms reflect genetic heterogeneity, although this theory has not been 
universally accepted due to reports o f the presence of both forms within one pedigree 
(see Chapter 3). The recent identification of the two genes. NYX  and CACNA1F. 
responsible for XLCSNB enables the investigation of such a genotype-phenotype 
correlation.
1.6 Molecular genetics of the inherited retinal dystrophies
More than 60 genes responsible for human retinal dystrophies have been identified and 
this knowledge paves the way for the development of novel therapeutic strategies which 
may help individuals with these disorders. Classification of retinal dystrophies has 
previously been based upon clinical phenotype and inheritance patterns. The increasing
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knowledge of the molecular pathophysiology of retinal dystrophies shows this purely 
clinical classification to be simplistic since for example, faults in many different genes 
result in the symptoms and signs of retinitis pigmentosa. Table 1 summarises our current 
knowledge of the genes involved in the causation o f retinal dystrophies.
1.7 The subject of this thesis
The subject of this thesis is X-linked congenital stationary night blindness with normal 
fundus appearance; this disorder will hereafter be referred to as XLCSNB in this thesis.
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Table 1: Summary of genes responsible for human retinal dystrophies 
(Adapted from Bessant et al. 2001)
Gene Locus Protein/protein function Inheritance Associated dystrophies
Phototransduction cascade (Table 2c)
RHO 3q21-q24 Rhodopsin AD RP, ADCSNB
GNAT I 3p22 a l  subunit o f transducin AD ADCSNB
PDEa 5q31.2-qtr a  subunit of PDE AR RP
PDEp 4pl6.3 y&ubunit of PDE AR RP
CNGCa 4pl4-ql3 AR RP
Recovery phase(Chapter 2.)
SAG 2q37.1 Arrestin AR Oguchi
RHOK 13q34 Rhodopsin kinase AR Oguchi
GUCA1A 6p21.1 Guanylate cyclase AD Cone dystrophy
Activating protein
GUC2D 17pl3.1 Retina specific guanylatei AD Cone-rod dystrophy
cyclase J AR Leber congenital
amaurosis
Structural proteins
RDS 6p21.1 Peripherin AD RP, macular dystrophy
Digenic RP
R O W  l lq !3 Rod outer segment Digenic RP
protein -1
Retinol metabolism
RLBP1 15q26 Cellular retinaldehyde AR RP
binding protein
RDH5 12ql3-ql4 11 -cis retinol AR Fundus albipunctatus
dehydrogenase
RPE65 lp31 all-/r<msretinyl ester AR Leber amaurosis
isomerohydrolase
ABCR 1 p21 -p 13 ATP binding cassette AR Stargardt disease
protein Cone-rod dystrophy
Transcription factors
CRX 19ql3.3 Cone rod homeobox AD Cone-rod dystrophy
AR Leber amaurosis
NRL 1 4 q ll.l- Increased rhodopsin AD RP
12.1 transcription
NR2E3 15q32 Ligand dependent AR Enhanced s-cone
transcription factor syndrome
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Table 1 cont.: Summary of genes responsible for human retinal dystrophies 
(Adapted from Bessant et al. 2001)
Gene Locus Protein/protein function Inheritance Associated
dystrophies
Proteins o f uncertain function
CRB1 lq 3 1-32.1 Crumbs AR RP
USH2A lq41 Usherin AR Usher (Type 2a)
EFEMP1 2pl6-p21 EGF containing fibrin AD Doyne ret dystrophy
like extracellular
membrane protein
PROML1 4p Prominin AR RP
TULP1 6p21.3 Tubby like protein 1 AR RP
RP1 8pll-q21 AD RP
USH1C llp l5 .1 Harmonin AR Usher (Type lc)
VMD2 1 lq l3 Bestrophin (RPE) AD Best
AIPL1 17pl3.1 Arrylhydrocarbon AR Leber amaurosis
interacting receptor
protein
MKKS 20pl2 Chaperonin AR Bardet-Beidl
McKusick-Kaufman
XLRS1 Xp22 Retinoschisin XL Retinoschisis
RPGR(RP3) Xp21 GTPase regulator XL RP
RP2 X pll.3 - XL RP
11.2
NYX X pll.23 Nyctalopin XL XLCSNB
Miscellaneous
PHYH lOpl 5.3- Phytanoyl CoA AR Refsum disease
12.2 hydroxylase
OAT 10q26 Ornithine AR Gyrate atrophy
aminotransferase
MY07A 1lql3.5 Myosin Vila AR Usher (type lb)
TIMP3 22ql3-qtr Tissue inhibitor of AD Sorsby fundus
metalloproteinase 3 dystrophy
NDP X pll.3 neuroectodermal protein XL Norrie, FEVR
CACNA1F X pll.23 alpha subunit of calcium XL XLCSNB
channel
REP1 Xp21 Rab escort protein XL Choroideraemia
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Chapter 2 Applied retinal anatomy and 
physiology
2.1 Functional anatomy of the retina
2.1.1 The cells and layers of the peripheral retina
The retina is a transparent membrane that varies in thickness from 0.1mm to over 
0.5mm. It lies in close anatomical and functional apposition to the retinal pigment 
epithelium (RPE). The RPE is a single layer of cuboidal cells which play a central 
role in the maintenance o f the transduction cascade through chromophore 
regeneration and participates in the renewal of photoreceptor protein and membrane 
components(Bok 1985). Six types of neurons may be identified in the retina: the 
photoreceptor cells, horizontal cells, bipolar cells, amacrine cells, interplexiform cells 
and ganglion cells. In the peripheral retina, these cells are organised into eight distinct 
layers (Figure 2a).
Figure 2a. The layers of the retina: (A) As seen in histological section, (B) Diagram of 
the arrangement of nerve cells. (Snell and Lemp 1989)
Pigment
epithelium Layer of rods and cones Outer limiting 
membrane
Outer limiting 
membrane
iU Outer 
.A nuclear
£  'ayer
^  Outer 
^  plexiform 
layer
Inner 
#  nuclear 
f l a y e r  
Inner 
I plexiform 
y layer
Layero^ S
^  ganglion 
cells
Layer of optic 
nerve fibers «=
Inner limiting membrane
I
Horizontal cell
Bipolar cell
Amacrine cell
Cell of Muller
Inner limiting membrane
Chapter 2: Applied retinal anatomy and physiology 2-20
A clinical and molecular genetic investigation of XLCSNB L E Allen
The retina has two types of photoreceptor cells, rods and cones (Figure 2b and c), 
characterized by different sensitivity to light: cones mediate vision in bright lighting 
conditions and give rise to colour vision, rods mediate vision in dim illumination. 
Rods and cones are highly specialized cells whose sensory portion, consisting o f inner 
and outer segments, is situated between the retinal pigment epithelium and the 
external limiting membrane. The outer limiting membrane is a row of zonulae 
adherentes connecting the inner segment o f the photoreceptors to the Muller cells and 
the Muller cells to each other. The Muller cell is of glial origin and spans nearly the 
full thickness of the retina. It has important roles in the structural development o f the 
retina, the maintenance o f potassium homeostasis and the degradation and regulation 
of synaptic transmitters in the retina. The photoreceptor outer segment is the site of 
phototransduction. It contains the stacked membranous discs derived from the 
photoreceptor cells' plasma membrane which contain the photopigments. The rod 
outer segment consists of a stack of flattened disc membranes (up to 2000 per rod) on 
which the light-capturing pigment molecules are embedded at high concentration.
The entire disc stack is completely covered by a single layer of plasma membrane. 
Cone outer segments are usually shorter than rods, have a different shape and are not 
separated from the overlying covering o f plasma membrane. Cone opsin is embedded 
in large, flat membrane surfaces that are not isolated discs but invaginations of the 
overlying plasma membrane. The outer nuclear layer (ONL) is occupied by the cell 
bodies of the photoreceptors.
The outer plexiform layer (OPL) contains the synapses between the photoreceptors 
and the bipolar and horizontal cells. Bipolar cells act as the major radially conducting 
element of the retina, transmitting signals either directly or indirectly from 
photoreceptors to ganglion cells. Bipolar cell axons course inwards into the inner 
plexiform layer to synapse with the dendrites of amacrine and ganglion cells. 
Horizontal cells have long processes which run laterally in the OPL and make contact 
with either rod or cone photoreceptors. Horizontal cells are the intemeurons of the 
outer retina, creating an inhibitory feedback onto the photoreceptors and a feed­
forward inhibition of bipolar cells (Masland 2001).
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The inner nuclear layer (INL) contains the cell bodies of the bipolar cells, horizontal 
cells, amacrine cells, interplexiform cells and Muller cells. The inner plexiform layer 
(IPL) contains the synapses of the amacrine cells with the dendrites of bipolar cells, 
interplexiform cells and ganglion cells. Amacrine cells are the interneurons of the 
inner retina and make lateral contact by synapsing with each other. They provide 
feedback connections with bipolar cells and feed-forward connections with ganglion 
cells. Interplexiform cells have processes which project to both plexiform layers. This 
cell appears to carry information from the inner to outer retina.
Ganglion cells in the ganglion cell layer are retinal neurons, their axons form the 
optic nerve and terminate in the lateral geniculate nucleus and superior colliculus. The 
dendrites of the ganglion cells receive synaptic inputs from bipolar and amacrine 
cells. The nerve fibre layer contains the ganglion cell axons and some astrocytes. 
Muller cell foot processes form the inner limiting membrane.
2.2 Topography of the retina
Microscopy reveals regional differences in retinal organization. In the human retina, 
cones are the only type of photoreceptor in the central region o f the fovea but outside 
this area rods begin to appear and sharply increase in number to reach a density of 
100.000 rods/mm2 at 1.2-1.7mm from the foveal center (Figure 2d) (Curcio. Sloan et 
al. 1990). The foveal region, on the optical axis of the globe, is 1.5mm in diameter. 
The centre of the fovea, the foveola, is 0.1mm in diameter and is free from cells 
except for the outer segments of cone photoreceptors. The parafoveal area is a region 
thickened by the heaped layers o f ganglion cells and cells of the inner nuclear layer 
displaced from the fovea. The macula surrounds the fovea, is approximately 6mm in 
diameter, and is characterized by a ganglion cell layer which is more than one cell 
thick.
2.3 Retinal neurophysiology
Whilst most neural cells act on all-or-none (or digital) basis, retinal neurons act 
through graded slow potentials, which are continuously shaped by the stimulus 
intensity, colour and geometry. The result is an analog computation which is only 
converted to a digital message at the last stage o f synaptic interaction. This analog
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method of synaptic interaction and the depolarization of photoreceptors in darkness 
allows continuous communication to second order neurons, ensuring that most retinal 
neurons are continuously modulated by synaptic activity throughout the functional 
range of light and dark.
2.3.1 Rod phototransduction
All photoreceptors respond to light with hyperpolarization, the degree o f which is 
dependent on the intensity and geometry of the light stimulus. The transduction 
process in rods has greater amplification than that in cones, making rods more 
sensitive to light.
Following exposure to light, an enzyme cascade occurs in the rod outer segments 
(Figure 2c). Absorption of light by rhodopsin leads to isomerization of its 11 -cis 
retinal component to the all trans form, resulting in a conformational change. This 
permits the binding and activation o f transducin. In the cytoplasm the active alpha 
sub-unit of transducin activates the enzyme cGMP phosphodiesterase (PDE). which 
then hydrolyses cGMP (Yamazaki. Havashi et al. 1990). The resulting drop in 
intracellular cGMP concentration closes cGMP gated cation channels on the plasma 
membrane o f the rod outer segment, leading to hvperpolarization of the rod cell 
plasma membrane (Yau and Nakatani 1985).
Several mechanisms are thought to turn the photoresponse off: rhodopsin kinase 
catalyses the phosphorylation of activated rhodopsin; arrestin. which preferentially 
binds to light-activated rhodopsin. may block further interaction with transducin: 
phosducin may bind to transducin preventing participation in multiple cycles of PDE 
activation (Shinohara. Donoso et al. 1988: Lee. Fowler et al. 1990). Additionally, a 
calcium-dependant feedback loop involving guanvlate cyclase activating proteins 
(GCAP-1 and GCAP-2) may increase the activity of retina specific guanvlate cyclase 
(RetGC-1 and RetGC-2). thereby restoring the cGMP concentration (Koch 1991). The 
transduction cascade may also be regulated by various calcium binding proteins: at 
low calcium concentrations, such as the environment found in light exposed rods. 
Recoverin may activate retina-specific guanvlate cyclase, which would offset the light 
triggered drop in cGMP. At high calcium concentrations, such as those found in the 
dark. S-modulin may amplify the on-response by inhibiting rhodopsin 
phosphorylation and enhancing activation of PDE (Dizhoor, Ray et al. 1991).
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Figure 2b: Structure of a rod and cone (from (Snell and Lemp 1989))
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2.3.2 Cone phototransduction
Cones respond to different wavelengths of light than rods. There are three types of 
cones in primates: s-cones. m-cones and 1-cones, which contain blue, green and red 
pigments that absorb light at 430, 530 and 569nm respectively (Brown and Wald 
1964). In all photoreceptors the chromophore group, 11 -cis retinal, is identical. The 
difference lies in variations of the amino acid sequence in the protein structure. 
Although the transduction cascade is similar to that already described for rods, the 
proteins and plasma membrane channels are distinct but not fully characterized.
2.3.3 Photoreceptor adaptation
The visual system is able to adapt to a very wide range o f light intensity. Under many 
conditions, this adaptation occurs within seconds, whether the background intensity is 
increasing or decreasing, and this ability of the visual system to rapidly alter its
sensitivity' is called light adaptation. This process involves the reduction o f cone
sensitivity caused by depletion of cone photopigment at intense ambient light levels, 
and modulation of the transduction enzymes by intracellular calcium, the level of 
which is reduced by constant light exposure. The term dark adaptation refers to the 
special case o f recovery o f the visual system in darkness following exposure of the 
eye to intense illumination that bleaches an appreciable fraction of the photopigment, 
rhodopsin. This recovery can be very slow, usually taking 40-50 minutes. The 
desensitization of the visual system is far in excess of the fraction of rhodopsin 
bleached and the time course of dark adaptation is mediated not only by the 
regeneration of this pigment but by the decay time of an active intermediate 
photoproduct metarhodopsin II (Leibrock. Reuter et al. 1998).
2.3.4 Transmission from photoreceptors
Photoreceptors communicate with bipolar and horizontal cells through chemical 
synaptic transmission. The major part of this transmission is mediated by release of 
synaptic vesicles through a calcium-dependent mechanism, although recent evidence 
suggests that a calcium-independent release mechanism may also be present 
(Schwartz 1986). Photoreceptors are depolarized in the dark and release the 
neurotransmitter glutamate at a maximal rate in the dark adapted state, the
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hyperpolarizing action o f light causes a reduction in the rate of neurotransmitter 
release (Ayoub and D.R.Copenhagen 1991.
2.3.5 Retinal circuitry of the rod and cone pathways
The primary rod and cone pathways are separate. Cones synapse onto several 
different types of cone bipolar cell. Some o f these are depolarizing bipolar cells, 
forming the cone ON pathway with a sign-inverting synapse. In addition cones 
synapse with hyperpolarizing (OFF) bipolar cells via a sign-preserving synapse in the 
cone OFF pathway.
Rods synapse with a single type of bipolar cell named the rod ON bipolar cell (Wassle 
and Boycott 1991). This, in turn, contacts the All amacrine cell at a sign-preserving 
glutamate synapse (Kolb and Famligetti 1974). Signals from the A ll amacrine cell 
then infiltrate the main cone circuitry by exciting ON cone bipolar cells and inhibiting 
OFF cone bipolar cells (Wassle, Grunert et al. 1995). Thereafter. ON bipolar cells 
excite ON ganglion cells and OFF bipolar cells excite OFF ganglion cells -  this is 
known as the slow rod pathway. A second rod pathway (the rod-cone coupling 
pathway, or fast rod pathway) infiltrates the ON and OFF cone bipolar circuitry at the 
earliest stage, through gap junction contacts allowing synaptic transmission (Kolb and 
Famligetti 1974).
In the central retina about 10 rods converge onto a single rod bipolar cell, whereas in 
the peripheral retina about 30 rods converge on a rod bipolar cell - this increases the 
signal to noise ratio. In comparison one cone, acting via a bipolar cell, may lead to the 
stimulation of one ganglion cell, preserving high acuity (Daw. Jensen et al. 1990). 
Rod-cone interactions occur via the horizontal cells of the inner retina. Horizontal 
cells have both rod and cone input and feed back in to the cone photoreceptors 
causing an inhibitory effect on cones in a dark adapted state. The rods, in effect, 
impose a low-pass filter on the cones (Arden and Hogg 1985).
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2.4 Visual function of the rod and cone systems
2.4.1 The effect of retinal position on visual function
Visual acuity rapidly diminishes as a stimulus is moved away from the fovea due to 
the fall in density of the cone photoreceptors and decrease in relative number of 
ganglion cells available to carry information away from the retina. The density o f rod 
and cone photoreceptors varies across the retina and this is reflected in changes in 
visual function elicited with testing. The knowledge of photoreceptor distribution is 
important since it allows the cone or rod system to be tested in isolation, solely cones 
will respond to a small stimulus presented to the foveal area. Conversely, tests for 
both cone and rod sensitivity are optimally performed if the stimulus image stimulates 
the retina between 10 and 18 degrees from the fovea - an area containing great 
numbers o f both receptor types (Figure 2d) (Siegel and Carr 1979).
2.4.2 The effect of light intensity on visual function
The rod photoreceptors mediate vision at low illumination levels and are responsible 
for the human retina's exquisite sensitivity to light. Rod photoreceptors operate over a
Q
10 range o f illumination from near darkness to daylight levels. Cone photoreceptors 
mediate vision at daylight levels and are responsible for good visual acuity and colour 
vision. The cones function over a 1011 range of illumination. Rod and cone sensitivity 
to illumination therefore overlap (Figure 2e) (Hood and Finkelstein 1986). The term 
“rod system'’ or “cone system" may be used to describe what is really a complex 
sequence o f neural processing after absorption of light rod and cone photoreceptors. 
The term “scotopic" illumination level is used to describe light levels where only the 
rod system is able to function, “photopic" level is used when only the cone system is 
able to function and “mesopic" level is used for the range o f illumination which 
stimulates both the rod and cone system. The luminance of a stimulus can be varied to 
isolate rod responses from cone responses: dim stimuli presented to a dark adapted 
eye will cause a purely rod response, whereas very bright stimuli presented to a light 
adapted eye will elicit a purely cone response.
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2.4.3 Spectral sensitivity
The probability of absorption of light energy by the visual photopigments in the outer 
segments o f the photoreceptors is dependent on the wavelength of the incident light. 
When sensitivity to light is measured in the dark adapted peripheral retina, a broad 
spectrum with greatest sensitivity at 507nm (blue-green) is observed. The spectral 
sensitivity curve represents the relative luminosities of the different wavelengths, so if 
a spectrum was produced in which each wavelength contained the same energy, the 
blue-green wavelength would appear brightest to the dark adapted eye. In photopic 
conditions, colour vision is mediated by three types of cone photoreceptors of 
different but overlapping spectral sensitivities. These are identified by their relative 
spectral position and are called the long, middle and short wavelength-sensitive cones. 
The combined activity of the long and middle wavelength-sensitive cones gives a 
broad spectrum of photopic spectral sensitivity peaking at 555nm (green-yellow). 
Scotopic (rod) and photopic (cone) spectral sensitivity curves based on the V \  and V> 
curves as defined by the CIE (Commission Internationale de f  Eclairage) are shown in 
Figure 2f. Rod photoreceptors are so insensitive to the extreme red end of the 
spectrum that it is possible to increase the luminance levels at this wavelength to 
allow photopic function without serious loss of dark adaptation. This principle is used 
to advantage in situations where optimum visual acuity is required while maintaining 
the sensitivity o f the dark adapted state, for example, photographic developing.
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Figure 2d: Density distribution of rods and cones in the horizontal meridian of 
the retina. The grey area represents the blind spot projection on the nasal side. The yellow 
area shows the area in which rod density is highest and cone density is low but constant -  
an ideal location for stimulation in the assessment of both rod and peripheral cone function. 
From (Osterberg 1935).
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Figure 2f: Rod and cone system spectral sensitivity curves.
The scotopic (rod) curve and photopic (cone) curve relative sensitivities are shown. The 
rod system is shown to be less sensitive than cones at the longest wavelengths of the 
visible spectrum.
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2.5 Introduction to clinical psychophysical testing
Clinical psychophysical measurements are non-invasive assessments of visual 
function utilizing subjective responses elicited to various visual stimuli. The stimuli 
may be varied to allow specific stimulation of particular photoreceptors enabling 
separate assessment o f the rod and cone system.
2.5.1 Measurement of visual acuity (VA)
VA is the ability to resolve fine detail in a pattern. Refractive aberrations and 
diffraction at the pupil edge are optical factors which limit VA. The density of 
packing in the mosaic of foveal cones is also an important limiting factor. Under ideal 
conditions, an observer with excellent vision can just resolve fine detail whose 
angular subtense approaches that of a single cone (Maturana. Lettvin et al. 1960).
VA is usually tested clinically by reducing the size o f a high-contrast test pattern until 
the smallest detail in the pattern can just be resolved and is expressed as the angle that 
detail subtends at the eye of the observer. Using such targets, visual acuity for normal 
observers ranges between 1 and 2 minutes of arc. VA is usually measured using an 
optotype chart, such as the Snellen chart. The accuracy of the Snellen chart is limited 
by its irregular progression in letter size from the easiest to most difficult lines, 
increasing number o f letters as the letter size decreases and varying difficulty of its 
letters. The logMAR chart improves on this since it has a geometric progression of 
letter height from line to line, decreasing by 0.1 log units per line and the letters used 
are o f equal difficulty (Ferris. Kassoff et al. 1982). VA may be notated by several 
different means: the Snellen fraction, the decimal acuity (division of the numerator of 
the Snellen fraction by the denominator) and the logarithm of the minimal angle of 
resolution (logMAR). The logMAR score is often used in clinical research since it 
provides reproducible VA in a format that facilitates quantitative data analysis.
2.5.2 Clinical evaluation of colour vision defects
Trichromatic vision extends 20 to 30 degrees from fixation, peripheral to this red and 
green become indistinguishable and in the far periphery all colour sense is lost. The
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very centre of the fovea (1 /8th degree) is blue blind due to the absence of short 
wavelength sensitive cones.
Defects in colour vision may be identified using a number of different clinical tests. 
Pseudoisochromatic plates are commonly used for screening colour vision and 
successfully detect 90-95% of congenital abnormalities (Pokomy and Smith 1994). 
The Ishihara series contains 16 testing plates and one control plate, the incorrect 
reading of tw o or more plates can identify protanopic and deuteranopic defects but not 
tritanopic defects (Figure 2g). The Hardy-Rand-Rittler (HRR) test plates contain 
symbols in colours close to the neutral points of protanopic, deuteranopic and 
tritanopic individuals. Colour symbols of low saturation are used as screening plates, 
and three higher saturations are used for the diagnostic plates. The HRR plates 
identify and differentiate between protanopia, deuteranopia and tritanopia. The 
Cambridge Colour Test is a computerised test, previously described by Regan (Regan, 
Reffin et al. 1994). This test uses luminance noise and masking contours to ensure 
that that the subject's responses depend solely on chromatic signals. The stimuli, 
generated by a computer graphics system, consist o f spatially discrete patches of 
varying size and luminance displayed on a black background. The field of the 
stimulus is formed by a majority of single chromaticity patches and the C shaped 
target is formed by a subset of patches o f contrasting chromaticity to the field (Figure 
2h). The orientation and chromaticity o f the target is systematically varied in 
successive presentations. The average luminance o f the target is always the same as 
that of the field. The array is viewed binocularly from a distance of 2.4m in dark 
surroundings and the subjects presses a button on a console corresponding to the 
orientation of the target C. Chromatic sensitivity may then be measured along 
different axes of colour space, protan, deutan and tritan confusion lines calculated and 
compared to control values.
Chromaticity discrimination tests usually rely on the subject's ability to arrange 
colours. The Farnsworth D15 and Famsworth-Munsell 100 Hue test utilize coloured 
paper strips which differ in hue but have approximately the same saturation and 
brightness for normal subjects. The City University and the Mollon-Reffin minimalist 
test (Figure 2g(ii)) use the same hue series. In the latter test, the subject is required to 
pick out a coloured chip randomly placed in a field of grey chips of varying 
brightness on the basis of hue only. Score patterns allow the identification,
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differentiation and grading of protanopic, deuteranopic and tritanopic defects 
(Mollon, Astell et al. 1991).
2.5.3 Perimetry
The normal field o f vision extends more than 90 degrees temporally, 60 degrees 
nasally and 70 degrees superiorly and inferiorly. Sensitivity is greatest at the fovea 
and decreases towards the periphery. An isopter is a line connecting the points in the 
peripheral visual field where a target of a specific size and intensity would be 
identified. The shape o f an isopter may become characteristically distorted when a 
disorder affects the visual pathways. Generalized reduction in sensitivity may result 
from ocular media opacity, constricted pupils or inadequate refraction.
Perimetry is a measurement o f the mean minimum detectable light stimulus in 
selected points in the visual field. Perimeters measure the minimum contrast between 
background illumination and stimulus, the threshold being the minimum measurable 
difference in luminance that the patient can detect. Visual fields may be measured by 
kinetic perimetry (e.g. the Goldmann perimeter) or static automated perimetry (e.g. 
the Humphrey perimeter). Whilst kinetic perimetry is useful for detecting relatively 
large field defects rapidly, it is less useful for detecting small scotomas and is less 
reproducible than static perimetry.
Automated perimetry may be performed with a variety of background and stimulus 
light intensities and wavelengths in order to assess the threshold sensitivity o f specific 
photoreceptors. Standard automated photopic perimetry (using a white light stimulus) 
may be mediated by foveal cones and peripheral rods. Rod or cone mediated function 
may be isolated and measured using short and long wavelength stimuli in scotopic 
conditions. In dark adapted normal eyes a blue stimulus will be sensed by the rod 
system and a red stimulus by the cone system (Fitzke 1995). However, the relative 
sensitivity of the rod and cone system may be altered in retinal disorders, making 
interpretation of scotopic perimetry more difficult: cone photoreceptors may mediate 
threshold to a blue stimulus in dark adapted conditions in diseases such as retinitis 
pigmentosa where there is extensive loss o f rod function.
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Figure 2g(i): Ishihara and City Figure 2g(ii): Hardy-Rand-Rittler and
University colour vision tests Mollon-Reffin minimalist tests
Figure 2h: Stimuli used in the Cambridge Colour Test. The top, middle and 
lower panels show protan, deutan and tritan test stimuli respectively. The left-hand 
stimulus of each pair is saturated, the right-hand stimulus represents a more difficult 
discrimination, (from Regan etal. 1993)
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2.5.4 Dark adaptometry
The normal dark adaptation curve following an initial bleaching light is biphasic, 
reflecting the dark adaptation of the cones and the rods. In the first phase, typically 
lasting 5-10 minutes, the threshold is determined by the cones as they recover from 
the pre-adapting bleach. The time course of the process parallels the regeneration of 
the cone photopigment. Later, the rods recover sufficiently for their thresholds to be 
lower than those of the cones and they mediate threshold, giving rise to the rod phase. 
A weak pre-adapting light results in a faster recovery of sensitivity and monophasic 
curv e reflecting the superior sensitivity o f the rods. A purely cone response (a 
monophasic curve with rapid recovery to pre-bleach thresholds) will be seen when 
dark adaptation is tested at the fovea, therefore dark adaptometry is usually performed 
between 18 and 20 degrees in the retinal periphery, where rod density is highest. The 
size, intensity, duration and colour of the stimulus are all important. Cones have 
almost equal sensitivity7 to red light as rods so the use of a red stimulus results in a 
dark adaptation curve with a prominent cone phase and little or no rod phase. Since 
rods are more sensitive to shorter wavelengths than cones, they mediate threshold 
earlier in the dark adaptation process when a blue stimulus is used, the resultant curve 
has a prominent rod phase with an early rod-cone break.
Retinal disease may elevate the absolute threshold of sensitivity and alter the kinetics 
of the dark adaptation curv e. Where there is extensive loss of rod function, cones may 
mediate threshold even under scotopic conditions so that the dark adaptation curve is 
monophasic with an elevated final threshold. Conditions in which the regeneration of 
rhodopsin is abnormally slow, for example fundus albipunctatus. have a prolonged 
rod phase but normal final thresholds after prolonged dark adaptation.
2.6 Introduction to the electroretihogram (ERG)
2.6.1 Components of the ERG
The electroretinogram (ERG) is a record of the combined electrical response 
generated by neural and non-neuronal cells within the retina as a response to a light 
stimulus. The ERG provides an objective measurement of total response of the retina 
and therefore may not detect localized retinal disease (Figure2i). The a-wave is the
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initial cornea-negative deflection of the ERG and is known to reflect the 
hyperpolarization response of the photoreceptors to light. The subsequent b-wave is a 
cornea-positive deflection, which represents a summation of responses but mainly 
reflects the extracellular current caused by ON bipolar cell depolarization (Newman 
and Odette 1984). The c-wave is a slow cornea-positive deflection comprising a 
summation of three different potentials, it is generally not used clinically since its 
long latency makes it subject to artifacts from eye movement. The d-wave (OFF 
response) is a comea-positive deflection occurring following the abrupt cessation of 
retinal illumination. It is produced by the OFF (hyperpolarizing) retinal pathway and, 
since only the cone system utilizes this pathway, is only present in photopic ERG 
conditions (Daw, Jensen et al. 1990). Oscillatory potentials are a series o f high 
frequency, low amplitude wavelets superimposed on the ascending limb o f the ERG 
b-wave after stimulation by an intense light flash. Although the cellular origin o f these 
potentials is uncertain, they are thought to be produced by the cone driven cells of the 
inner retina, which are supplied by the retinal circulation, such as the amacrine or 
interplexiform cells (Heynen. Wachtmeister et al. 1985). The photopic negative 
wave (PhNR) has recently been described and forms a negative potential after the b- 
wave o f the photopic ERG (Colotto. Falsini et al. 2000: Viswanathan. Frishman et al. 
2001). This response is thought to derive from the inner retina, either directly from the 
retinal ganglion cells or through mediation by glial cells. The PhNR can be measured 
in photopic conditions using the standard bright flash or the longer flash stimulus 
required for measurement of the ON-OFF response.
2.6.2 The normal human ERG
By varying the background lighting conditions and intensity o f light stimulus, the 
ERG can be used to identify specific retinal responses. The response of a dark adapted 
retina to a dim white or blue flash (scotopic conditions) will yield a purely rod 
mediated response. The a-wave in these conditions gives information about rod 
photoreceptor function while the characteristics of the scotopic threshold response 
(STR). b-wave and oscillatory potentials give information about the rod pathway in 
the inner retina. Light adaptation and stimulation with a bright or fast flickering 
stimulus (photopic conditions) will isolate a cone mediated response. As the stimulus 
intensity and background illumination increase to favor a cone mediated response, the 
ERG waveform increases in amplitude and decreases in latency. The cone pathway
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through the inner retina can be tested by the characteristics of the b-wave, oscillatory 
potentials, 30Hz flicker response, ON-OFF response and photopic negative response 
in light adapted conditions.
2.6.3 Factors affecting the ERG
Various factors such as stimulus duration and form of light stimulation affect the 
amplitude and latency o f the ERG. For this reason a standard for clinical 
electroretinography has been drawn up by International Society for the Clinical 
Electrophysiology of Vision (ISCEV) (Marmor and Zrenner 1998). An ocular media 
opacity7, such as a cataract, reduces the retinal illumination, thereby reducing the ERG 
amplitude and prolonging the implicit time. The high axial length associated with 
myopia of more than -6 .0  dioptre spheres (DS) is associated with reduction in ERG 
amplitude.
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Figure 2i: The normal electroretinogram
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Chapter 3 Review of the previous clinical 
investigation of CSNB
3.1 Clinical and psychophysical manifestations of CSNB
Many o f the studies mentioned in this chapter are based on a genetically heterogeneous 
population of XLCSNB and ARCSNB subjects. This limits the comparisons and 
conclusions that can be drawn from them.
3.1.1 Symptoms
The cardinal symptom of CSNB is a non-progressive night blindness but a variable 
reduction in daytime vision may also occur. Since an affected individual has no 
knowledge of normal night time vision, they may not be symptomatic with their night 
blindness, particularly if they live in a brightly lit city (Price, Judisch et al. 1988). 
Children are especially unlikely to complain of night blindness, although their parents 
may notice that they cling on to them in poorly lit situations. Children are most 
commonly diagnosed when an ERG is performed to find the cause of their reduced 
visual acuity and nystagmus. There may be no apparent family history since older 
members may never have had ERG testing. Before ERG testing was routinely available, 
these individuals may have been misdiagnosed as having congenital motor nystagmus 
or ocular albinism.
3.1.2 Visual acuity
Daytime visual acuity is usually subnormal in subjects with XLCSNB, the severity of 
this visual loss often showing inter and intra-familial variability (Pearce. Reedyk et al. 
1990). Previous studies of XLCSNB have reported the visual acuity to range from 6/6 
and counting fingers vision (Merin, Rowe et al. 1970; Hill, Arbel et al. 1974). More 
recent studies have indicated that there is not a significant difference between recorded 
decimal visual acuities in the “complete” form (0.42 and 0.38) and “incomplete” form 
(0.41 and 0.30) of AR and XLCSNB (Miyake, Yagasaki et al. 1986; Ruether, 
Apfelstedt-Sylla et al. 1993).
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3.1.3 Refractive state
Although the refractive error in XLCSNB is usually high myopia, it may range from 
mild hypermetropia (+4.0DS) to high myopia (up to -20.0DS) (Carroll and Haig 1952; 
Haim 1986; Khouri, Mets et al. 1988; Pearce, Reedyk et al. 1990; Tremblay, Laroche et 
al. 1995). Miyake reported a significant difference between the refractive error in the 
“complete” form (-7.0+/-8.1DS) and “incomplete” form (-0.8+/-10.8DS) of AR and 
XLCSNB but a study by Ruether found no significant difference (Miyake, Yagasaki et 
al. 1986; Ruether, Apfelstedt-Sylla et al. 1993). Miyake later concurred that 
hypermetropia, emmetropia and, myopia may coexist within the same pedigree (Miyake
1989). Anisometropia and an astigmatic refractive error may be present but are usually 
mild (Merin, Rowe et al. 1970; Khouri, Mets et al. 1988; Pearce, Reedyk et al. 1990).
3.1.4 Extra-ocular movements
Strabismus is a frequent finding in individuals with XLCSNB, occurring in 17-100% 
but there appears to be no predominance between exotropia and esotropia (Hill, Arbel et 
al. 1974; Miyake, Yagasaki et al. 1986; Ruether, Apfelstedt-Sylla et al. 1993). 
Exotropias are reportedly more common in “incomplete” AR and XLCSNB and 
esotropias more so in the “complete” form (Ruether. Apfelstedt-Sylla et al. 1993). 
Nystagmus commonly accompanies XLCSNB but is not a consistent feature (Haim 
1986; Miyake, Yagasaki et al. 1986; Ruether, Apfelstedt-Sylla et al. 1993). In most 
reports the nystagmus is horizontal in direction and either fine or coarse but fine 
rotatory nystagmus has also been described (Merin. Rowe et al. 1970; Krill and Martin 
1971).
3.1.5 Colour vision
Many studies have reported subjects with XLCSNB as having normal colour vision but 
mild tritan and protan colour vision defects have been reported in both “complete” and 
“incomplete” forms of AR and XLCSNB (Hittner. Borda et al. 1981; W olf and Weber 
1984; Miyake, Yagasaki et al. 1986).
3.1.6 Spectral sensitivity
Studies of spectral sensitivity show a reduction in threshold sensitivity to short and long 
wavelength stimuli. The shape of the spectral sensitivity curve fits the shape of the CIE
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scotopic sensitivity curve for wavelengths shorter than 600nm and the CIE photopic 
sensitivity curve at longer wavelengths, indicating that long wavelengths are mediated 
by a desensitised cone system and shorter wavelengths are mediated by a desensitised 
rod system (Sharp et al. 1990).
3.1.7 Visual field examination
Photopic perimetry is usually normal. Specific visual field abnormalities relating to 
tilting of the optic disc or level of ametropia may be present (Hittner, Borda et al. 1981; 
Ruether, Apfelstedt-Sylla et al. 1993). A reduction of sensitivity with eccentricity from 
the fovea has also been identified, a feature associated with high myopia (Terasaki, 
Miyake et al. 1999). Blue-on-yellow perimetry has identified normal foveal blue cone 
sensitivity- but a significant reduction in sensitivity to the stimulus in the peripheral 
retina in subjects with the “complete’' form of AR and XLCSNB (Terasaki, Miyake et 
al. 1999).
3.1.8 Ocular examination
Fundoscopy is generally normal in XLCSNB. However, myopic fundus changes may be 
present and many affected subjects have tilted, pale or dysplastic optic nerve heads. 
Miyake noted a gold metallic reflex in the mid-peripheral retina in 16 out of 20 subjects 
with “incomplete” AR and XLCSNB studied (Miyake. Yagasaki et al. 1986). Can- 
described cases with a granularity at the macula, which blunted the normal foveal reflex 
(Carr, Ripps et al. 1966). Retinal arteriolar narrowing and peripheral pigment clumping 
are not seen in this condition. Paradoxical pupillary reflex (pupillary constriction in the 
dark) has been described in a number of young children with CSNB of unspecified 
inheritance (Barricks. Flynn et al. 1977; Khouri, Mets et al. 1988). This phenomenon 
has not been reported in older subjects.
3.1.9 Systemic abnormalities
Systemic abnormalities associated with the recessive forms of CSNB have not been 
reported.
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3.1.10 Dark adaptometry
Psychophysical studies have identified two distinct types o f dark adaptation curves in 
subjects with AR and XLCSNB (Auerbach, Godel et al. 1969; Miyake, Yagasaki et al. 
1986). Subjects with the “incomplete” form of recessive CSNB have been shown to 
have a bipartite curve with elevated final threshold, illustrating the presence o f residual 
rod and cone function. Miyake found subjects with the “complete” form of AR and 
XLCSNB to have a monophasic curve with an elevated residual cone threshold 
indicating that rod function is absent and cone sensitivity is reduced (Miyake, Yagasaki 
et al. 1986; Miyake, Yagasaki et al. 1987). Another group has shown bipartite curves in 
both AR and XLCSNB but a delayed rod-cone break in the latter (Sharp, Arden et al.
1990).
3.2 Photochemistry in CSNB
Rhodopsin density and its regeneration kinetics have been consistently normal in 
XLCSNB (Carr 1974; Sharp, Arden et al. 1990). Vitreous fluorophotometry has 
confirmed that the blood-retinal barrier is intact in AR and XLCSNB (Miyake, Gto et 
al. 1983).
3.3 The electrophysiology of CSNB
3.3.1 Introduction
The ERG plays an important diagnostic role in CSNB. As might be predicted, the 
amplitude o f the scotopic response is reduced in all forms, however the photopic 
response may also be abnormal. The two main ERG patterns first described in CSNB 
were the Schubert-Bomschein (Schubert and Bornschein 1952) and the Rigg?s (Riggs 
1954) types. More recently, differences have been detected in the Schubert-Bomschein 
form of CSNB, resulting in its sub-classification into “complete” and “incomplete” 
types (Table 3a) (Miyake, Yagasaki et al. 1986).
3.3.2 The Rigg’s type ERG
The Rigg's type ERG is found in ADCSNB and is characterized by a subnormal 
scotopic b-wave amplitude but, since the b-wave remains larger in amplitude than the a-
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wave, the b-wave to a-wave ratio is greater than one (Figure 3a). The scotopic ERG 
response also has the temporal characteristics and waveform of the photopic response. 
The a-wave amplitude has been reported as normal (Riggs 1954;Auerbach et al. 1969) 
but a more recently, using a brighter flash stimulus, a-wave responses in the dark 
adapted retina have been reported as subnormal (Sharp, Arden et al. 1990). The Rigg’s 
pattern ERG is most commonly associated ADCSNB (as demonstrated by the Nougaret 
family) (Carroll and Haig 1952; Francois, Verriest et al. 1956; Sharp, Arden et al. 1990) 
but has been reported in recessive pedigrees (Auerbach, Godel et al. 1969).
The subnormal and shorter latency waveform seen in the ERG under scotopic 
conditions is thought to arise as a response from a desensitized retina (Sharp. Arden et 
al. 1990). The relative bipolar cell: photoreceptor sensitivity may be measured using the 
b-wave to a-wave ratio. This is normal in Rigg’s type CSNB indicating that 
transmission at the photoreceptor cell / bipolar cell synapse is unaffected (Carr and 
Siegel 1964). Reduction in the photoreceptor dark current generates the a-wave and this 
change affects the activity of the post-synaptic neurons, the bipolar cells, resulting in the 
b-wave. Since both a- and b-waves appear subnormal in this form of CSNB it has been 
predicted that the fault might lie in the transduction cascade (Sharp, Arden et al. 1990). 
This theory has since been confirmed by the identification of mutations in genes 
encoding rod photoreceptor transduction cascade enzymes in affected autosomal 
dominant pedigrees: a-subunit o f cGMP phosphodiesterase (Gal. Orth et al. 1994). a - 
subunit o f transducin (Dryja. Hahn et al. 1996) and rhodopsin (See Chapter 4) (Dryja, 
Berson et al. 1993; Sieving. Richards et al. 1995; al- Jandal, Farrar et al. 1999).
3.3.3 The Schubert-Bornschein type ERG
The Schubert-Bomschein ERG is characterised by a “negative wave” response 
occurring to bright light stimulation of the dark adapted retina. Characteristically the a- 
wave in this form of CSNB is normal both in latency and amplitude but the b-wave is 
subnormal, resulting in a b-wave to a-wave ratio less than one (Figure 3a)(Schubert and 
Bomschein 1952). This pattern of ERG has been identified in all hereditary forms of 
CSNB (Auerbach. Godel et al. 1969; Miyake, Yagasaki et al. 1986; Noble. Carr et al. 
1990; Miyake and Kanai 1992). The normal a-wave amplitude reported by many 
authors in both scotopic and photopic conditions has led to the conclusion that 
photoreceptor function is normal in CSNB, however, very recent studies have indicated
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that there may also be subtle rod photoreceptor dysfunction (Hansen et al. 
2001;Langrova et al. 1999). The subnormal b-wave amplitude, leading to a reduced b- 
wave to a-wave ratio, has indicated that a fault in neurotransmission between the 
photoreceptor and second order neurons may be the cause (Carr and Siegel 1964). This 
theory is supported by recent genetic analysis of families with XLCSNB: gene 
mutations resulting in abnormal glutamate neurotransmitter release from photoreceptor 
presynaptic terminals have been identified in affected subjects (See Chapter 4) (Bech- 
Hansen, Naylor et al. 1998; Strom, Nyakatura et al. 1998).
In 1986, Miyake demonstrated that other ERG characteristics could be used to further 
sub-classify subjects with the Schubert-Bomschein ERG (Table 3a). On the basis of 
electrophysiological and psychophysical examination two distinct sub-types could be 
identified(Miyake, Yagasaki et al. 1986). "Complete” AR and XLCSNB was 
characterized by the absence of a rod mediated response but normal photopic responses. 
"Incomplete” CSNB was distinguished from the complete form by the presence o f a 
detectable but subnormal scotopic response and, additionally, by a subnormal photopic 
response. This group also found that the b-wave to a-wave ratio was significantly lower 
in the “complete” pattern of recessive CSNB than in the “incomplete” form. Miyake 
demonstrated that subjects from each pedigree could consistently be assigned into either 
the complete or incomplete sub-groups, with no pedigree showing both types, and 
postulated that the sub-groups represented different clinical entities. This sub­
classification has become accepted despite the description of other pedigrees whose 
ERG characteristics do not allow their allocation into either "complete” or "incomplete" 
categories (Khouri. Mets et al. 1988; Pearce. Reedyk et al. 1990; Aldred. Dry et al. 
1992).
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Table 3a: Classification of CSNB by ERG
Schubert-Bornschein ERG Riggs ERG
Scotopic a-wave: normal Scotopic a-wave: normal or 
subnormal
Scotopic b-wave: subnormal or absent Scotopic b-wave: subnormal
b/a-wave ratio < 1 b/a-wave ratio > 1
Oscillatory potentials: absent / subnormal
Complete pattern Incomplete pattern
Scotopic b-wave: absent Scotopic b-wave: 
subnormal
Photopic b-wave: normal Photopic b-wave: 
subnormal
30Hz flicker: normal 30Hz flicker: subnormal
Figure 3a: Comparison of normal, Schubert-Bomschein and Rigg’s and ERG 
waveforms
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3.3.4 The scotopic threshold response
The scotopic threshold response (STR) is a cornea-negative response measured near the 
psychophysical absolute threshold of vision in the dark adapted eye. At higher 
intensities this response is masked by the b-wave. Retinal depth recording in the cat eye 
has shown that the STR originates in the proximal retina at the junction of the inner 
plexiform and ganglion cell layers. It is thought to reflect the Muller cell response to 
extracellular potassium ions released by these neurons (Sieving, Frishman et al. 1986). 
Miyake tested the STR of six subjects with ARCSNB or XLCSNB, two were 
determined to have the “complete” form and the other four the “incomplete” form on 
ERG testing. The STR was absent in the subjects with “complete” CSNB. An STR of 
normal amplitude but delayed latency could be identified in subjects with the 
“incomplete” form but present, albeit at an elevated stimulus intensity threshold than 
controls. The authors suggest that, because the STR reflects proximal function in the rod 
visual pathway, there is a disturbance in the transmission of the rod signal to the rod 
bipolar cells in “complete” CSNB and that a different mechanism is responsible for the 
“incomplete” form (Sieving and Nino 1988; Miyake. Horiguchi et al. 1994).
3.3.5 Oscillatory potentials (OPs)
OPs may be detected in the ERG waveform as a response of the dark or light adapted 
eye to a bright, Standard Flash stimulus. OPs recorded in the dark adapted eye have 
been reported as subnormal or absent in the “complete” CSNB group but o f normal 
amplitude in the “incomplete” form, conversely. OPs in the light adapted eye have been 
reported as absent in the “incomplete” form with only one peak identifiable in the 
“complete” form.(Lachapelle. Little et al. 1983; Miyake. Yagasaki et al. 1986;
Tremblay. Laroche et al. 1995) This suggests that in the “incomplete” form the cone 
system does not respond optimally under the normal operating range (photopic 
conditions) but rather has its best responses under mesopic or scotopic conditions 
possibly indicating the disruption of normal rod/cone interaction.(Lachapelle, Little et 
al. 1983; Tremblay, Laroche et al. 1995)
3.3.6 30Hz flicker response
The amplitude o f the 30Hz flicker response has been identified as being subnormal and 
double peaked in the “incomplete” form of recessive CSNB but of normal amplitude in
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the “complete” form.(Miyake et al. 1986 Miyake described an exaggerated increase in 
response amplitude during light adaptation but this has not been confirmed by other 
studies.(Miyake, Horiguchi et al. 1987; Tremblay, Laroche et al. 1995) Although the 
30Hz flicker response has been demonstrated as being of normal amplitude in 
“complete” AR and XLCSNB, an unusual “squared o f f ’ waveform appearance has been 
described.(Heckenlively, Martin et al. 1983; Siegel, Greenstein et al. 1987)
3.3.7 The ON-OFF response
The ON and OFF responses are tested in photopic conditions, the positive ON response 
generated by the ON (depolarizing) bipolar cells and the positive OFF response 
generated by a combination of the cone photoreceptors and the OFF (hyperpolarizing) 
bipolar cells. The two responses therefore give complimentary information about the 
cone pathway through the inner retina. The ON response is, by definition, subnormal in 
all Schubert-Bomschein type CSNB. The OFF response (or d-wave) has been found to 
be normal in the “complete” but subnormal and delayed in the “incomplete” form 
(Miyake et al. 1987c; Quigley et al. 1996; Houchin et al. 1991; Langrova et al. 2002).
3.3.8 The photopic negative response (PhNR)
The PhNR is a negative wave response which follows the b-wave under photopic 
conditions. The amplitude of the response may either be measured as part of the 
photopic SF test condition or to a long light stimulus such as that used in the recording 
of the ON-OFF response. This wave originates from the inner retina, probably as a 
consequence of the spiking activity of retinal ganglion cells. This response may be a 
sensitive measure o f retinal dysfunction in patients with diseases that affect the inner 
retina. Reduction in the amplitude of the response has been identified in subjects with 
glaucoma.(Colotto. Falsini et al. 2000; Viswanathan. Frishman et al. 2001) This 
response has not previously been evaluated in CSNB.
3.4 Visual evoked potential recording
The visual evoked potential (VEP) is a recording of the electrical response of the brain 
to a visual stimulus. Many responses are averaged in order to filter out other EEG 
activity. Individuals with abnormal nerve fibre decussation at the optic chiasm may be
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the occipital response, which reverses in distribution when the other eye is tested, may 
indicate excessive decussation o f fibres at the optic chiasm, a characteristic feature of 
oculo-cutaneous and ocular albinism (see VEP protocol in Chapter 6).
Trembley identified a crossed asymmetry VEP pattern in 9 out of 10 AR and XLCSNB 
subjects tested who had ERG patterns suggestive of the “incomplete” type (Tremblay et 
al. 1996). Although is has been suggested that Aland Island eye disease (AIED see 
3.6.1) is indistinguishable from “incomplete” CSNB, studies have failed to demonstrate 
crossed asymmetry o f the VEP in AIED families tested (Glass et al. 1993; van Dorp et 
al. 1985).
3.5 The ERG in female carriers of XLCSNB
Miyake studied the ERGs o f 12 obligate female carriers o f XLCSNB and determined 
that whilst the latency and amplitude of their a and b-waves were within normal limits, 
the amplitude of their oscillatory potentials was subnormal (Miyake and Kawase 1984). 
This finding was later confirmed by Young who found that this feature could be 
optimally identified by measurement of the third OP peak amplitude in the response of 
the dark adapted retina to a blue flash stimulus (Young et al. 1989).
3.6 Other disorders causing a “negative” ERG waveform
The “negative” ERG waveform is not specific to CSNB but may be seen in a variety of 
retinal disorders, most of which can be excluded by adequate evaluation (Table 3b). 
Two conditions, however, Aland Island Eye Disease and Oregon Eye Disease do bear a 
close resemblance to CSNB and are surrounded by controversy.
3.6.1 Aland Island Eye D isease (AIED)
This was first described by Forsius and Eriksson in 1964 and named after the homeland 
of the original reported family (Forsius and Eriksson 1964). AIED is a non-progressive 
disorder characterized by reduced visual acuity and dark adaptation, colour vision 
abnormalities, high axial myopia, astigmatism, nystagmus, foveal hypoplasia, and 
fundal hypopigmentation (Glass et al. 1993; Rosenberg et al. 1990; Waardenberg et al. 
1969). Although initially thought to be a variant o f ocular albinism (OA2), the absence
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al. 1990; Glass, Good et al. 1993). Although initially thought to be a variant of ocular 
albinism (OA2), the absence of iris translucency in half the subjects and the limitation 
o f fundus hypopigmentation to the posterior pole in the condition were atypical 
(Witkop, Quevedo et al. 1983). Additionally, subsequent electrophysiological 
examination and skin biopsy failed to show the visual pathway misrouting and skin 
macromelanosomes characteristic of albinism (van Dorp et al. 1985;Witkop et al. 1983). 
Dark adaptometry has documented abnormal scotopic thresholds and an abnormal rod- 
cone transition. ERG studies have demonstrated subnormal scotopic and photopic b- 
wave amplitudes, subnormal 30Hz flicker responses and subnormal scotopic oscillatory 
potentials (Glass, Good et al. 1993).
The similarity between the clinical and ERG findings in AIED and “incomplete” 
XLCSNB is striking and has led to the suggestion that these conditions may be a single 
disease entity, or that AIED may represent a subset of the condition (Weleber, Pillers et 
al. 1989; Glass, Good et al. 1993). This theory has been supported by linkage studies, 
which have mapped AIED to proximal Xpl 1, the same region as the CSNB2 locus 
(Figure 4a) (Alitalo, Kruse et al. 1991; Schwartz and Rosenberg 1991; Hawksworth, 
Headland et al. 1995). Andrassi screened 3 families with AIED related phenotype and 1 
family with classic AIED for mutations in CACNA1F, his group identified loss-of- 
function mutations in the three AIED related phenotype families but no mutation in the 
family with classic AIED(Andrassi, Alitalo et al. 1999).
3.6.2 Oregon eye d isease
This disorder is clinically similar to AIED/ “incomplete” CSNB but is part of the 
syndrome of complex glycerol kinase deficiency (Duchenne-type or Becker's muscular 
dystrophy, glycerol kinase deficiency and congenital adrenal hypoplasia). Pillers 
reported the clinical features of this disorder in five affected children, they included 
reduced visual acuity, night blindness, ametropia and variable iris and fundus 
hypopigmentation. The ERG showed marked reduction in scotopic b-wave amplitudes, 
subnormal photopic b-wave amplitudes and subnormal oscillatory potentials. Complex 
glycerol kinase deficiency in these cases was caused by a deletion in Xp21. Due to the 
marked similarity between the ocular features of this disorder and AIED/ “incomplete” 
CSNB, the authors suggested that another locus for AIED/ “incomplete” CSNB may
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occur in Xp21 (Weleber, Pillers et al. 1989; Pillers, Seltzer et al. 1993). They named the 
eye condition associated with complex glycerol kinase deficiency Oregon eye disease. 
Studies o f the ERG in boys with Duchenne muscular dystrophy (DMD) have identified 
a “negative” waveform in a proportion o f subjects (Cibis, Fitzgerald et al. 1993; De 
Becker, Riddell et al. 1994). DMD is caused by deletions in the dystrophin gene located 
on Xp21 and dystrophin has been identified in the photoreceptor-bipolar synaptic 
complex, although its function remains unknown (Pillers, Bulman et al. 1993; Schmitz, 
Holbach et al. 1993). The negative waveform ERG associated with DMD is, unlike 
Oregon disease, not associated with any visual disturbance or fundal abnormality 
(Jensen, Warburg et al. 1995).
Table 3b: Conditions associated with a “negative wave” ERG
Condition Scotopic ERG response 
a-wave b-wave
Photopic ERG 
response
a-wave bwave
Congenital stationary disorders'. 
Complete CSNB 
Incomplete CSNB 
Aland Island Eye Disease 
Oregon eye disease 
Oguchi disease
normal
normal
+/-sL
normal
+ /-^
nLnI/nP
nLvLnL
normal
normal
+/-vL
normal
normal
+/-nU
4/ 4/
4/4/
4/4/
+/-4/4z
: d  i ;>h!i i t \  v t r < / PH ; \ ' s
Early retinitis pigmentosa 
Infantile Refsum disease 
Goldmann-Favre vireoretinopathy 
X-linked retinoschisis 
Cone dystrophy
+ /-^
+/-4/
+/-4/
4/nL
4/ 4/ 4/
4/ 4/
+/-vL
+/-sL
4/ 4/
+/-sL
+/-4>
+/-4/
+/-4
4/ 4/ 4/
4/ 4/
4/4/
+/-44'
Melanoma associated retinopathy normal normal 4/ 4/
I 'aseiilar disorders:
Ischaemic central retinal vein 
occlusion
Central retinal artery occlusion
+/-sL
+/-4>
+/-4/4z
+/_4/4z +/-nU +/-4/nL
Retinal toxicity:
Quinine
Vincristine
+/-4r
normal
4/ 4/
4/ 4/ ^
+/-4'
normal
+/_4/4z
normal
Optic atrophy normal +/-sL4' normal +/-4
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Chapter 4 Previous genetic investigation of 
XLCSNB
4.1 XLCSNB Linkage studies
The earliest genetic studies excluded linkage of XLCSNB to the loci of colour blindness 
(Xqter) and to the XG locus (Xpter) (White 1940; Volker-Dieben and Went 1975). 
Subsequent studies demonstrated that the disorder was closely linked with the locus 
DXS7 (Gal. Schinzel et al. 1989; Bech-Hansen, Field et al. 1990). Musarella confirmed 
this finding in pedigrees exhibiting either “complete” or “incomplete” clinical forms of 
XLCSNB (Musarella, Weleber et al. 1989). The mapping of this locus was further 
refined to between the loci MAOA and DXS426 (Xpl 1.3 to Xpl 1.23) (Aldred, Dry et 
al. 1992; Bech-Hansen, Moore et al. 1992). At this time there was considerable 
uncertainty whether the disorder was genetically heterogeneous or if the wide variation 
in phenotype might result from a single disease locus (Khouri, Mets et al. 1988; Pearce, 
Reedvk et al. 1990).
The genetic heterogeneity of XLCSNB was clearly established when Bergen 
demonstrated a novel locus at Xp21.1 in one clinically heterogeneous family (Bergen, 
ten Brink et al. 1995). Boycott suggested that two loci, one for “complete” (CSNB1) 
and one for “incomplete” (CSNB2) XLCSNB might account for all reported mapping 
information. Following genetic and clinical analysis of 32 pedigrees the CSNB2 locus 
was refined to the region between DXS722 and DXS255. in Xpl 1.23. The CSNB1 
locus was refined to the region between DXS556 and DXS8083, in Xpl 1.4-Xpl 1.3 
(Figure 4a) (Hardcastle. David-Gray et al. 1997; Boycott, Pearce et al. 1998).
4.2 Identification of the CSNB2 gene -  CACNA1F
Efforts to identify the CSNB2 gene led to the construction of high-density maps of the 
Xpl 1.23 region. Sequencing revealed several new genes including CACNA1F, a novel 
L-type calcium channel ai-subunit gene spanning 28kb (Strom et al. 1998;Bech-Hansen 
et al. 1998b). This gene appeared a likely candidate gene for XLCSNB since ERG 
studies had indicated that the condition might result from a defect in synaptic 
transmission between photoreceptors and bipolar cells (Hood and Greenstein 1990). 
Retinal studies in frog retina had also illustrated that glutamate release from
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photoreceptor presynaptic terminals is mediated by L-type (long lasting) 
dihydropyridine sensitive calcium channels (Schmitz and Witkovsky 1997). 
Additionally, several neurological and neuromuscular disorders in humans and night 
blindness in Drosophila are known to result from mutations in calcium channel otl- 
subunit genes (Smith 1996; Doyle and Stubbs 1998).
4.2.1 Properties of the gene CACNA1F
CACNA1F is 48 exons in length with a coding sequence of 5901 nucleotides and a 
predicted protein length o f 1966 amino acids (219.5kD). Expression of CACNA1F is 
limited to retinal tissue (Strom et al. 1998;Bech-Hansen et al. 1998b) and RNA in situ 
hybridisation studies have identified its transcription products in the outer nuclear layer 
(containing the photoreceptor cell bodies), the inner nuclear layer (containing 
horizontal, bipolar and amacrine cells) and, more weakly, in the ganglion cell layer 
(Strom. Nvakatura et al. 1998).
4.2.2 Structure and function of the L-type calcium channel
L-type calcium channels consist of 4 subunits (a j. aj, P, and y. the calcium conducting 
pore and the voltage sensor being located in the ai-subunit (Catterall 1995). Three 
autosomal L-type calcium channel aj-subunit genes have previously been cloned: a\s  
from skeletal muscle (Hogan. Powers et al. 1994), ocic from cardiac muscle and brain 
(Schultz 1990) and a  id from neural and endocrine tissues (Williams 1992).
Figure 4b illustrates the structure o f the ai-subunit of an L-type calcium channel. The 
aj-subunit is comprised of four repeat segments (I-IV). each containing six 
transmembrane domains (S1-S6). The similarity between the amino-acid sequence of 
the human ajd-subunit gene and that of CACNA1F is 70% overall and 84% in the 
transmembrane segments. Sequence identity between CACNA1F and. the other L-type 
channels is present in the charged residues of the S4 regions which act as voltage 
sensors (Stuhmer 1989) and the dihydropyridine binding sites at IIIS5-S6 and IVS6 
(Schuster 1996). The amino acids at the P-subunit binding site after the first segment is 
also conserved (Pragnell 1994).
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4.2.3 Mutation analysis of the gene CACNA1F
Having identified CACNA1F  as a candidate gene for “incomplete” XLCSNB, Strom 
and Bech-Hansen screened a total of 33 pedigrees with this clinical form of the disorder 
for mutations. Using a single-stranded conformation polymorphism (SSCP) technique, 
Strom screened 39 o f the 48 exons for mutations and identified nine different mutations 
in 10 of the 13 pedigrees (five missense mutations, four protein truncating mutations) 
(Strom, Nyakatura et al. 1998). Bech-Hansen screened 20 families with “incomplete” 
CSNB for mutations in CACNA1F  using direct DNA sequencing and identified 
mutations in all 20. The six different mutations resulted in premature stop codons 
causing protein truncation (Bech-Hansen, Naylor et al. 1998).
4.2.4 Pathophysiological effect of CACNA1FIoss-of-function mutations
Loss-of-function mutations in CACNA1F  result in inactivity of the L-type calcium 
channel. This form of XLCSNB is not the only example of a retinal channelopathy; rod 
monochromatism has recently been determined to result from loss-of-function 
mutations in CNGA3. a gene located on chromosome 2ql 1. This gene encodes the a- 
subunit of the cone photoreceptor cGMP-gated cation channelling a potassium channel 
sub-unit in the cone photoreceptor (Kohl, Marx et al. 1998).
On the basis o f the ERG pattern of Schubert-Bomschein type CSNB, it has been 
postulated that the disorder is caused by defective neurotransmission between 
photoreceptors and bipolar cells. The a-wave of the ERG response is of normal 
amplitude, indicating that the photoreceptor current is normal but the b-wave is severely 
reduced in amplitude, reflecting an abnormally reduced level of light induced 
depolarization in the ON bipolar cells of the inner retina. Theoretically this pattern 
could result either from a decrease in the amount of neurotransmitter released from the 
photoreceptors or the effectiveness of the transmitter at the post-receptoral site (Hood 
and Greenstein 1990).
In darkness, glutamate is tonically released from the photoreceptor presynaptic terminal 
whilst light-induced photoreceptor hyperpolarization diminishes the release of the 
neurotransmitter. The reduced stimulation of the ON bipolar cell by released glutamate 
in light conditions results in its depolarization (Stockton and Slaughter 1989). Loss-of- 
function mutations affecting the aj-subunit of the L-type calcium channel impair the 
influx o f calcium ions into the photoreceptor presynaptic terminals thereby diminishing
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the tonic release of glutamate and allowing the ON bipolar cells to be relatively 
depolarized (light adapted) in darkness. The effect of this is to limit the synaptic gain 
between the first and second order retinal neurons (Bech-Hansen, Naylor et al. 1998; 
Strom, Nyakatura et al. 1998).
4.3 Identification of the CSNB1 gene - NYX
More recently the CSNB1 locus has been identified on Xpl 1.4 using positional cloning 
and a candidate gene approach (Bech-Hansen, Naylor et al. 2000; Pusch, Zeitz et al. 
2000). Analysis with gene finding software predicted a novel gene, NYX  at this locus.
4.3.1 Properties of the gene NYX
N YX  is a 3 exon gene with a full length sequence of 1443 nucleotides encoding a protein 
of 481 amino acids named nyctalopin. Transcript size and tissue distribution were not 
detectable by Northern analysis due to the low level o f expression of this gene, however 
RT-PCR results indicated expression in retina, kidney, brain, muscle, placenta and testis 
(Bech-Hansen. Naylor et al. 2000; Pusch, Zeitz et al. 2000). As is the case with 
CACNA1F, ATT is apparently expressed in the photoreceptor, bipolar, amacrine and 
ganglion cells (Bech-Hansen, Naylor et al. 2000; Pusch, Zeitz et al. 2000).
4.3.2 Structure and function of nyctalopin
Nyctalopin contains an N-terminal signal peptide and a C-terminal 
glycosylphosphatidyl (GPI) anchor. The central part of the protein encodes 11 
consecutive leucine-rich repeat (LRR)motifs which are flanked by N- and C-terminal 
cysteine rich LRRs. This structure qualifies nyctalopin as a new extracellular member of 
the subfamily o f the small leucine-rich proteoglycan (SLRP) family (Iozzo 1997).
Figure 4c illustrates a three-dimensional model of nyctalopin.
Members of the LRR superfamily are involved in regulation of cell growth, cell 
adhesion and axon guidance (Kobe and Deisenhofer 1994; Hocking, Shinomura et al. 
1998). Nyctalopin has approximately 30-35% identity with other SLRP family members 
including Karatocan (mutations in which have been shown to cause comeal plana) and 
chondoadherin (Pellegata, Dieguez-Lucena et al. 2000). Other superfamily members 
that have GPI-anchors include Drosophila chaoptin, an extracellular photoreceptor 
neuron-specific cell adhesion molecule (Krantz and Zipursky 1990), and Drosophila
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connectin, which acts as a repulsive guidance molecule during motoneuron growth cone 
guidance and synapse formation (Nose, Takeiki et al. 1994). Nyctalopin may therefore 
have important function as a developmental regulator o f synaptic formation between rod 
photoreceptor cells and postsynaptic neurones including bipolar and amacrine cells.
4.3.3 Mutation analysis of NYX
Two groups have performed N YX  mutation analysis by direct DNA sequencing on 46 
pedigrees with “complete” CSNB, to date 29 different mutations have been identified. 
These mutations include point mutations (16 different missense mutations, 2 nonsense 
mutations), 8 deletions and 3 insertions. These identified mutations all result in loss-of- 
function of nyctalopin by disrupting vital regions of the protein, for example the 
deletion of 326 base pairs in exon 3 o f one family and a nonsense mutation in another 
both result in absence o f the GPI anchor, thereby making the protein soluble rather than 
membrane bound.
4.3.4 Pathophysiological effect of NYX  mutations
The functional role of nyctalopin in the retina remains to be clarified but loss of protein 
function evidently causes the diverse clinical features o f CSNB1. If the protein is 
required to establish or maintain functional contacts between rod photoreceptor cells 
and postsynaptic neurons of the inner retina, loss of function might be predicted to 
result in a disconnection of these synaptic circuits.
4.3.5 The nob Mouse Model
A naturally occurring mouse model of XLCSNB was described in 1998 (Pardue.
McCall et al. 1998). The nob (no b-wave) mouse demonstrates similar 
electroretinographic features as human subjects with XLCSNB. Recently mutations in 
the mouse nyx gene have been identified in affected mice, making it an extremely 
useful model for defining the role o f nyctalopin in signal transmission between 
photoreceptors and retinal bipolar cells (Gregg, Mukhopadhyay et al. 2003). Using this 
mouse model, Ball et al. have demonstrated that the absence of nyctalopin does not 
result in the disruption in the expression pattern of other proteins known to be required 
for synaptic transmission, such as the ai-subunit of the L-type calcium channel and 
dystrophin (Ball, Pardue et al. 2003).
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Figure 4a: Diagrammatic representation of the X chromosome, illustrating the 
position of the CSNB1 and CSNB2 gene loci.
 1 CSNB1
^ -----1 CSNB2
Figure 4b: Structure of the voltage-gated calcium channel alphai-subunit. The
subunit contains 4 repeat domains containing 6 transmembrane domains (S1-S6)
(from Strom et al 1998).
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Figure 4c: 3D modelling of nyctalopin.
The structure is represented as a ribbon, beta-sheets in light blue, alpha-helices in yellow and 
numbering of the leucine-rich repeats is highlighted in blue. Basic amino acid residues lining the 
inner surface of the protein are depicted with their side chains in blue and acidic amino acids in 
red. (from Pusch et al. 2000)
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4.4 Other inherited retinal conditions mapping to Xp
Many other retinal disorders also map to this area of the X chromosome (Figure 4d).
The gene for X-linked cone dystrophy (COD1) and the genes responsible for three 
phenotypic forms X-linked retinitis pigmentosa (RP2, RP3 and RP15) have been cloned 
and map to Xp21.1-pl 1 (Meindl, Dry et al. 1996; Schwahn, Lenzner et al. 1998; 
Seymour. Dash-Modi et al. 1998; Mears, Hiriyanna et al. 2000). The RP6 locus has 
been mapped to the region between DXS 1048 and STR44 (Ott, Bhattacharya et al. 
1990). The fact that night blindness is an early symptom of RP and the finding that 
ADCSNB and RP are allelic (Dryja, Berson et al. 1993; Rao, Cohen et al. 1994) raised 
the speculation that a similar situation might exist with the X-linked forms of both 
disorders. However, recent cloning of the CSNB1 and CSNB2 genes (Section 4.3) has 
disproved this. The gene causing AIED, a condition possibly indistinguishable from 
“incomplete” XLCSNB, has been localised to the region between DXS7 and DXS255, a 
region overlapping the CSNB2 gene locus. This indicates that the conditions may be 
one and the same or allelic (Glass, Good et al. 1993).
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Figure 4d:Inherited ocular d isease map for proximal Xp
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Chapter 5 Summary of review
5.1 Summary of review and problems remaining
From this review o f the literature it can be seen that there are many controversies 
surrounding CSNB.
Many of the problems associated with the clinical classification of CSNB lie with the 
absence o f standardisation o f electrophysiological procedures. Most of the studies 
were performed before the ISCEV standardisation of ERG protocols in 1989. 
Additionally, ERG results from two different sets of recording equipment are not 
directly comparable. This lack of standardisation may explain why some authors have 
suggested that some subjects can not be classified as having either “complete’' or 
“incomplete'’ CSNB according to Miyake’s criteria, and that both forms of the 
condition may occur in one pedigree. Miyake’s study included subjects with 
XLCSNB and ARCSNB and could not attempt to make a genotvpe-phenotype 
correlation. The molecular genetic studies that have been performed have, necessarily, 
involved subjects who have been examined in many different centres across the world 
and do not provide adequate information on phenotype.
The improvement in the standardization of psychophysical and electrophysiological 
testing and the advancement in the understanding of the molecular genetics of 
XLCSNB by the recent identification o f the two genes responsible for the condition 
provide an exceptional opportunity to investigate the presence of a genotvpe- 
phenotype correlation in this condition.
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5.2 Aims of this project
The aims of this study are:
1) To accurately document the phenotype of affected subjects in families with 
XLCSNB.
2) To investigate the functional deficit of the scotopic and photopic system in 
subjects with XLCSNB, evaluate possible disease mechanisms and to confirm 
or refute the existence o f the “complete” and “incomplete” clinical subtypes.
3) To test families with XLCSNB for a causative gene mutation and investigate 
the possibility of a genotvpe-phenotype correlation.
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Chapter 6 Investigation of XLCSNB: Methods and 
protocols
6.1 Ethical Committee approval
Ethical committee approval was given for this study by the Cambridge Regional 
Ethical Committee in 1998.
6.2 Diagnostic criteria
The criteria for diagnosis of XLCSNB were:
1) The symptom o f non-progressive nyctalopia
2) Normal visual field examination
3) Grossly normal fundoscopic examination
4) The presence o f a ‘negative wave' ERG in affected males.
6.3 Identification of pedigrees and recruitment of patients
Families with CSNB were identified mainly from the Genetic Clinic database at 
Moorfields Eye Hospital and from the East Anglian Regional Genetic Clinic 
Database. A letter providing information about the study and inviting the referral of 
additional pedigrees was sent to Clinical Geneticists and Consultant Ophthalmologists 
throughout the UK. Subjects with a diagnosis of CSNB were contacted by post with 
information regarding CSNB. details o f the proposed project and a questionnaire 
regarding their family history o f the condition (Appendix A). Twenty three affected 
subjects from 15 pedigrees who fulfilled the above criteria gave written informed 
consent to participate in the study.
6.4 Ophthalmic examination
Twenty subjects from 12 of the original 15 pedigrees were able to attend for 
standardised ophthalmic examination. Individuals from the other 3 pedigrees agreed 
to give blood for DNA analysis. The twenty affected subjects and immediate family 
members were examined prospectively. Information was recorded on a standardised
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data sheet (Appendix B) subsequently data was entered onto a computerised database 
for analysis. A general ophthalmic history was recorded with particular attention paid 
to the history o f nyctalopia, deterioration in visual acuity, colour vision deficiencies, 
previous therapy for amblyopia or strabismus and family history. A full ophthalmic 
examination including refraction and slit-lamp biomicroscopy was performed. A-scan 
measurements o f the ocular axial length were performed in older children and adults.
6.5 Psychophysical examination
Visual acuity was tested using Snellen and logMAR charts. Colour vision was tested 
using the HRR plates, Ishihara plates, City University plates, the Mollon-Reffm 
‘minimalist te sf and where possible the Mollon-Reffm digital colour vision test. 
Photopic perimetry was tested using a Goldmann perimeter. Older children and adults 
were invited to attend a further appointment for further psychophysical testing 
(scotopic perimetry and dark adaptometry) at the Institute o f Ophthalmology, London.
6.5.1 Scotopic perimetry
A Humphrey Field Analyser (HFA) was modified to allow measurements in scotopic 
conditions and control by an external computer for spectral sensitivity measurement 
and dark adaptometry. The apparatus and method for scotopic perimetry and dark 
adaptometry using this equipment has been described previously (Steinmetz, 
Haimovici et al. 1993; Downes, Fitzke et al. 1999).
In amblyopic subjects the non-amblyopic eye was tested; where the visual acuity was 
the same in each eye. the right eye was selected for testing. Testing followed 
pharmacological mydriasis with 1% cyclopentolate and 40 minutes of dark 
adaptation, scotopic perimetry was performed prior to dark adaptometry.
Scotopic perimetry was recorded using red (predominant wavelength 650nm) and 
blue (predominant wavelength 450nm) targets corresponding to Goldmann size V 
over the 30-2 HFA grid. Threshold intensity for these targets was determined at two 
pre-assigned retinal locations (-9, +9 and +9,-9 on the HFA 30-2 grid).
6.5.2 Dark adaptometry protocol
The 450nm and 650nm Goldmann size V targets were used for dark adaptometry. An 
initial pre-bleach threshold value for each target was determined at -9,+9 and +9.-9
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on the HFA 30-2 grid. A 2 minute period of light adaptation (equivalent to 7.5 
scotopic troland seconds), sufficient to bleach more than 95% of available rhodopsin, 
was achieved using lights installed within the perimeter bowl. The testing strategy 
used a method o f ascending limits in which the stimulus was presented at 3.5 second 
intervals, and after each response the stimulus intensity for each location and target 
stimulus was reduced by 7dB for the first three responses and 3dB for subsequent 
responses. They were then increased by ldB until the next response was recorded. 
Threshold measurements were continued in the dark for at least 45 minutes (or longer 
depending on the subject’s tolerance). Dark adapted thresholds were considered 
abnormal if there was a KMB (1 log unit) or greater elevation when compared with 
age matched controls. The rod-cone break was determined by visual inspection. 
Return of pre-bleach sensitivity was defined as the time at which the average of the 
last five measurements came within 5dB (0.5 log units) of the average of the pre­
bleach threshold measurements.
6.5.3 Spectral sensitivity protocol
Spectral sensitivity to additional stimuli of wavelength 488nm, 520nm, 590nm and 
633nm was also assessed prior to dark adaptometry.
6.6 Electrophysiological examination
All twenty subjects underwent standardised electroretinography. During the course of 
the research project a new piece o f testing apparatus became available which enabled 
the recording of the ON-OFF response in a number o f the subjects.
6.6.1 ERG protocol
Several international professional bodies have published recommendations for 
recording the ERG. While the ERG protocol used for this project complies with the 
standards set by the International Society for Clinical Electrophysiology of Vision 
(ISCEV) (Marmor and Zrenner 1998), we have used gold foil electrodes for our 
subjects and controls rather than the contact lens electrode used with a speculum 
which they recommended. Although gold foil electrodes are not as sensitive as 
contact lens electrodes, they are in more common clinical use across the UK and are 
much more likely to be tolerated by children without the need for sedation or the risk
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of corneal abrasion. Other workers have also justified the use of gold foil electrodes.
In children too young to tolerate the gold foil electrode, a gold skin electrode was 
used (Kriss and Russell-Eggitt 1992).
The ERG was recorded by means o f a gold foil electrode located in the inferior fornix 
of the tested eye. In children who were unable to tolerate the foil electrode, a gold disc 
electrode was positioned on the lower eyelid. Gold disc electrodes were positioned 
mid-frontally (Fz) and on the forehead as reference and ground electrodes 
respectively. The ERG signal was amplified with a gain of 1 x 104 over a bandwidth 
of 0.8-800Hz and fed into an analog-to-digital converter of the laboratory computer 
system. The computer sample rate was 1 kHz and the sweep time 200ms (rod 
responses) or 100ms (cone responses). Four to 64 responses were averaged, 
depending on signal size.
The stimulus was a lOps Xenon flash (Grass Instruments PS22) delivered via a
diffusing sphere (Ganzfeld) so as to provide full-field even illumination of the eyes.
Stimulus intensity was measured with an integrating photometer fitted with a
• 1 2luminance barrel and photopic filter. The maximum stimulus intensity was 7cd.s" .m" , 
which complies with the recommended level for the Standard Flash ‘Maximal 
response' ISCEV standard. Stimulus intensity was controlled by means of neutral 
density filters (Kodak Wratten). During the course of the test the subject's eyes were 
monitored with a low light level camera.
The pupils were dilated with 1% tropicamide and the eyes dark adapted for 20 
minutes. The ERG recording electrodes were positioned under dim red illumination 
and rod responses were then recorded to stimuli of increasing intensity. Cone function 
was tested using a red flash under dark adapted conditions. The eyes were then 
exposed continuously to a rod desensitising background of 25cd.m" for 10 minutes. 
Cone responses were then recorded to the Standard Flash and to a 30Hz flicker. 
Scotopic oscillatory potential amplitudes were isolated by passing the ERG response 
elicited in dark adapted conditions using the Standard Flash through a 100-300Hz 
digital filter, photopic oscillatory potential amplitudes were isolated by the same 
means under light adapted conditions.
The ERG responses o f 26 adult control subjects aged 19-62 years were used to 
provide normal latency and amplitude data.
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6.6.2 Scotopic Threshold R esponse protocol
The STR intensity series was recorded with a gold foil electrode in the same manner 
as the ERG protocol above. The pupils were fully dilated with 1% tropicamide and 
recording initiated after 20 minutes o f dark adaptation. The stimulus was presented at 
2 second intervals. The STR intensity series was recorded initially with the Standard 
Flash stimulus attenuated by up to -7.2 log units by a neutral density filters then with 
increasing stimulus intensity in 0.3 log unit steps until the STR was abolished by the 
scotopic b-wave. The dark adapted ERG was then recorded.
6.6.3 ON-OFF response protocol
The ON-OFF responses were elicited using a long flash stimulus in a second ganzfeld 
system. The system incorporated two independent 250 watt tungsten halogen lamps 
mounted in fan cooled lamphouses. The colour temperature of the light was 
approximately 3000 deg K. Light was collected from each lamphouse over a wide 
angle by an aspheric lens mounted adjacent to the exit port of the lamphouse. A
second aspheric lens brought the beam to a focus at the centre o f a fast electronic
shutter. Infra-red and ultra-violet wavelengths were removed by appropriate filters in 
the light path. Additional neutral density filters in each light path controlled stimulus 
and background intensity. A 20mm fiber optic bundle collected the light at exit from 
the shutter. The bundle then split into 4 tails which were positioned at equidistant 
points around the front o f the ganzfeld bowl and directed the beam via diffusers onto 
the inner surface o f the bowl. The tails from the two systems were interleaved around 
the front of the bowl. One system with the shutter continuously open provided the
—7background adapting light which was set to 48 ph cd.m ; the other system provided
—2the stimulus which was set to 320 ph cd.m . The flash duration was controlled by an 
electronic shutter with 90% rise and fall times of 5ms. The duration of the light period 
was 200ms and that o f the dark period 150ms. The data acquisition sweep time was 
300ms and 50 responses were averaged for each trial. At least two responses were 
recorded to ensure data quality and reliability and the two or more responses were 
then averaged off-line for response peak cursoring.
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6.6.4 VEP protocol
The VEP protocol followed the recommendations made by Apkarian (Apkarian, Reits 
et al. 1983). The stimulus was a large (60’) appearing (300ms onset) and disappearing 
(500ms offset) black and white chequerboard pattern of field 20 (horizontal) by 18 
(vertical) field generated on a computer display screen. The white square luminance 
was 80cd.m‘" and the contrast was 98%. The screen was viewed at a distance of 
100cm and a 10' red square centered within the stimulus field served as the fixation 
spot. Adequate fixation was assessed by closed circuit television. VEPs were recorded 
using 5 disc electrodes placed 3cm apart in a horizontal row. 3cm above the inion 
with the central electrode located at the midline. Reference for all electrodes was the 
common ground electrode was located on the mid-frontal position (Fz) on the 
forehead. Signals were amplified with a gain of l ( f  over a bandwidth of l-100Hz. 
Each trial was the average o f one hundred presentations.
Monocular left and right eye responses were recorded. At least two independent trials 
were obtained to stimulation of each eye for confirmation that the waveform was 
reproducible. The two (or more) responses were computer averaged off-line and the 
hemispheric ‘difference" signal computed by subtracting the right hemispheric 
response from the left hemispheric response when each eye was stimulated in turn. 
The difference potential resulting from stimulation of each eye was then plotted and 
the polarity o f the difference potential compared qualitatively in the period 80-110ms 
after pattern onset. The presence o f reversal in the difference potential from right to 
left eye stimulation was considered to be evidence of response asymmetry due to 
misrouting.
6.7 Molecular genetic analysis
6.7.1 DNA extraction from blood samples
Following informed consent and after clinical examination. 20mls of peripheral 
venous blood was taken in EDTA tubes from all subjects and was stored at +4°C prior 
to DNA extraction. Genomic DNA was extracted from peripheral blood samples 
using the Nucleon II kit (Scotlab Ltd, Strathclyde, Scotland) at the Molecular Genetic 
Laboratory at Addenbrooke’s Hospital. This process involves the segregation of 
leucocytes from erythrocytes and disruption o f the leucocyte nuclear and cytoplasmic
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membranes to release genomic DNA. Cellular proteins are then removed by 
denaturation and extraction using organic solvents and DNA precipitated from 
aqueous solution by the addition of ethanol.
6.7.2 Mutation screening of the genes CACNA1F and NYX
The DNA from affected males in 15 pedigrees was screened for mutations in the 
CACNA1F gene by the author at the Cambridge Institute for Medical Research in 
Cambridge. During the course o f the project the N YX  gene was identified: DNA from 
the subjects in whom CACNA1F gene mutations had not been detected was then 
screened for mutations in AFX by Dr Alison Hardcastle and colleagues in the 
Department o f Molecular Genetics at the Institute of Ophthalmology, London.
Affected male DNA was PCR amplified for the 48 exons of CACNA1Fusing primers 
and conditions outlined in Table 6a (Strom, Nyakatura et al. 1998). Buffer recipes are 
described in Appendix C. Affected male DNA was subsequently PCR amplified for 
the exons of ATX, primers and conditions are outlined in Table 6b. The magnesium 
ion concentrations required are shown and all reactions were annealed at 60°C with 
1 jliI of DMSO in N H 4 Reaction Buffer (Bioline, London, UK).
The PCR products were purified using the Qiagen purification kit (Qiagen Ltd, 
Crawley, UK) according to the manufacturer's instructions and then directly 
sequenced using a Big-dye terminator cycle sequencing kit (Perkin-Elmer-Applied 
Biosystems, Warrington UK) and a fluorescent sequencer (ABI 373) according to the 
manufacturer's instructions (Appendix C). Segregation analysis of observed sequence 
changes was performed using the gain or loss of a restriction endonuclease site in all 
available family member DNA. Previously unreported nucleotide sequence changes 
were determined to represent significant mutations rather than polymorphisms by 
screening a population o f 100 unrelated Caucasian males for the nucleotide change. 
Where the same mutation was identified in multiple pedigrees, the possibility of a 
founder effect was evaluated by amplification of microsatellite markers around the 
gene as previously described (Hardcastle, Thiselton et al. 1999).
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Table 6a: Primers and conditions for polymerase chain reaction (PCR) of CACNA1F  exons
Exon primer Annealing
Temperature
°C
Buffer Exon primer Annealing
Temperature
°C
Buffer
1F: ACAAACGTCCCATTTGCAC 
1R: GCAATGGGTGGGTCAGAG
61 NEB 15F:AGCCTATTTGAGCCCAACCT 
15R: ACCCATCCCATGGTCTCC
61 P1
2F: ATACCCTGTCCCTCCCTGAC 
2R: CT CCTGGT ACCCT GAT G ACC
Touchdown
63,61,59
NEB 16F: G AGCT CC AC AGT G ACTTCCC 
16R:ACCCTGCCTATAGACCACCC
66 P1
3F: GAGGTTCCCAAGGGAGTAGG 
3R: GTCTGGCTGGAAGGAGTGAG
65 P1 17F.GTGGTCTATAGGCAGGGTGC
17R:GACTGTGTTAGGGGTGGAGC
60 P1
4F:CTCGGTCCTGACTATGCTCC 
4R: GGTAGGAAGGCGACTAGGGT
60 NEB 18F:GTAGTGATCCCCCTTAGCCC
18R:ACAGGTAGTGGTGGGAGTGG
Touchdown
63,61,59
P1
5F: AT CCC AAGGCCT G ACCT C 
5R: ACCCTCCACCTCCGACCT
58 P1 19F: CCT C ACC ATT GAT G ACTCCC 
19R:TGTCTGCCTGAGCTCTTTCC
60 NEB
6F: CTTATTTCTGCCTCCCCCTC 
6R: AGC ATT GG AT CT AGG AACCG
Touchdown
63,61,59
P1 20 F: TTTT GCTTTT CT CT GGT GCC 
20R:GGCTCACCTAGGGCTCTTCT
61 NEB
7F: CAAGCTCCAGTCTTCCTGC 
7R: T G AGT GT C AGGG AGG AAAGG
60 P1 21 F:TCAGGGCCAGAACTGTATCC 
21 R:GTCCCCTCAGCTCCTAGCTC
61 NEB
8F: GG AT GC AT GCCTTTT CT CT C 
8R: GTTTGCCAGGCACAAAGAAG
61 P1 22F:GAAGTCACCTAGGATCCCCC 
22R: C AACT GAGGGT AGGACT GGG
62 P1
9F: TAGCCCTCTATCCTCCTCCC 
9R: GGAGGGCAG ACC AC AT CT AA
61 NEB 23/24F:TCCCC AGGT CT GAGT CT AGC 
23/24R: GTCCT GT GGGTTTGGGT G
63 P1
10F: AATT GTCCTTT CT CT CCCTGC 
10R:TCCAATCTTTGGCTTTCACC
62 P1 25/26F: GT AGCCAT ATGCTT GGGT GC 
25/26R:AGTCTTTGGGAGGGGTCCT
Touchdown
65,63,61
P1
11F: AGGTCCTGACCACTATCCCC 
11R: GG ACTT G AGT C AGGGTTT GG
61 NEB 27F: AACCT GTTTGC AC ATCC AC A 
27R:CTGCCTCATCCCCTGATAAA
58 NEB
12 F: TTT ACGACACACACCTCCCA 
12 R: ATC C AA AG GT CAT GAG G GCT
60 P1 28F:ACCTGCCCCCACCTCTAC
28R:ACCATCCATAGGGGGTCAG
60 P1
13F: AGGGC AGGCTTAGGTAGGTG 
13R: AGAAGGAATAGGAGGCTGGG
61 P1 29F.ATGCCCTGCCCTGGTATG
29R:ATAGGGTCAGGAGTCTGGCG
58 P1
14F:GATCATCCCTGCCTCTCTCC
14R:CTTCCCCCTCCCCTAATACA
61 NEB 30F:AATATTTGGTTGGGTGTGGC
30R:CCCAAGGAATTCATCCACTG
57 P1
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Table 6 a -  continued: Primers and conditions for PCR of CACNA1F exons
Exon Primer Annealing
Temperature
°C
Buffer Exon primer Annealing
Temperature
°C
Buffer
31 F.GACAGGGCACTGCTTTTCTC 
31 R:CAGGAGTAGGGAGGATGTGC
61 NEB 40F:TCTTCCTATTGGCTCATGCC 
40  R: AGC GAT CAT CTG C C ATT C AG
62 NEB
32F:CTCCACCTT GTT CATTT GGGC 
32R:GGACATGGGAAAAGAAGCAG
Touchdown
65,63,61
NEB 41 F:CCCTGTGTGATCTTGCCTTC 
41 R.CCATCCACACTAGGCCCTG
61 NEB
33F:AAATGCAAACTGAGCATCCC 
33 R: ATTT G G AAAT GGGTATGGCA
60 P1 43F:GTGCATGCAACACT CAGT CC 
43R:CTCAACTTCCTGCCTCCTGA
58 P1
34F:GACTGCATCTCCCAGTAGGC
34R:ATTCTTAACCCATCCCCTGC
59 P1 44F:ATCTGGTCTGCCTAACGTGC
44R:CAGTTCCCACCCCTCCTC
Touchdown
65,63,61
NEB
35F:GTAGGGGTGGCAGGTAGACA
35R:GTGGCAGGGGAGTGAGTAGA
60 NEB 45F:GACTGTTTGTGCCCCATCTC
45R:TTCCCCAGATCTCTGTCCTG
61 P1
36F:GATGTAGCCCCTGGTGAGAA
36R:GGTGGTTGTGAGGAAATGGT
59 NEB 46F:CTGACATTGCTATTTGCCCC
46R:CATCTCTCCAGACCCCAGAC
Touchdown
65,63,61
NEB
37F : ACAGTGTT CT GCCCTT CACC 
37R:TAATGAGATGCAGCAGTCGG
61 NEB 47F:AGCGGTGAGTCCTAGACCCT
47R:GACTCCTTTCCGTCCTCCTC
Touchdown
65,63,61
NEB
38F:AGTGGTACCTCCCCAACTCC
38R:CCACCCTTGCCATGTGATAG
61 P1 4 8 F : AACACT GAT CCCACCT GTGC 
48R:GAATTCAGAGGGCGTGGAC
61 P1
39F:ACATTCGTTCCTGCATACCC
39R:ATGAGTTTGCTCCTTGCACC
61 P1
Table 6b: Primers and conditions for PCR of NYX  exons
Exon Primer Annealing
Temperature
°C
Buffer
MgCI2
Exon Primer Annealing 
Temperature °C
Buffer
1F: ACCTTT ACTT CT CT C AAACCA 
1 R:GGCATCACTGACAACCCAGC
61 15mM 3bF:ACAACCTGTCCTTCATCACGC
3bR:CAGGTTGAGCGGCGCAGG
61 10mM
2F:ATGAAAGGCCGAGGGATGTTG
2R:CCAACATCCCTCGGCCTTTCA
61 10mM 3cF:GACTGTGGCGTCCTGGAGC
3cR:GGTCACCTGGCTGAGGTCC
61 10mM
3aF:GACCTTTGGCTGACGGTTGC
3aR:GTGCAGGTAGCGCAGGTCG
61 15mM 3dF:ATGGAGGGCTCCGGACGTG
3dR:TTACCACAAACACAACTCAAGCC
61 15mM
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Chapter 7 Molecular Genetics Results
Mutation screening for CACNA1F, using direct DNA sequencing, was performed on the 
15 pedigrees which fulfilled the diagnostic criteria for XLCSNB.
7.1 Mutation screening of CA CNA1F
Comprehensive mutation screening o f the CACNA IF  gene revealed 3 different mutations 
in 3 families, all predicted to cause protein truncation and therefore loss of function 
(Table 7a, Figure 7a). The novel nonsense mutation detected in exon 7 (family X10) 
occurs after the fifth transmembrane domain (Figure 4c) therefore deleting part of 
Segment I and all o f Segments II. Ill, IV, the EF-hand motif and cytoplasmic C- 
terminus. This sequence change results in loss of a digest site for the restriction enzyme 
BseR I and was found to segregate with the disease in this family (Figure 7b). The single 
base deletion in exon 9 detected in family X I 1 results in a frameshift at amino acid 
position 341 resulting in loss of domains and motifs downstream from Segment I and 
predicted loss o f function. This mutation has previously been identified in one other 
family (Bech-FIansen, Boycott et al. 1998). The third loss-of-function mutation (family 
X I2) was identified in exon 24 resulting in protein truncation in Segment III and has also 
been previously identified in a single family (Strom. Nyakatura et al. 1998).
Two polymorphic variants were detected in the CACNA IF  gene (1647C>T and 
3114T>C). which were not predicted to alter the amino acid sequence. A third 
polymorphism was found in families X04 and X05. namely a G>A transition at 
nucleotide position 5595. which resulted in a conservative amino acid substitution from 
arginine to histidine. The sequence change was confirmed by the presence of a new HpH 
I restriction enzyme digest site (Figure 7c), this sequence change was identified two of 
the first 50 normal males to be tested, indicating that this was not a disease causing 
mutation (Figure 7d). These polymorphisms have not previously been reported. 
Subsequently. N YX  gene mutations were identified in both X04 and X05 pedigrees.
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Table 7a: CACNA1F sequence changes identified in subjects with CSNBX.
Pedigree Exon Sequence change* Codon change Type „
X10 7 637G—»T E213X Stop (Novel 
mutation)
X I 1 9 1023delC D341delC Frame shift 
(stop378)
X01 14 1647C—>T None Polymorphism
X12 24 2719C—>T R904X Stop
X02 28 3114T—>C None Polymorphism
X04 48 5595G—>A R1865H Polymorphism
X05
* position according to Af067227
7.2 Mutation screening of NYX
Mutation screening o f the ATX gene was subsequently performed on affected males from 
the 12 pedigrees in which C /IC A ^/F  mutations were not identified. A total of 7 different 
mutations segregating with disease were identified in the NYX  gene in 11 different 
families (Table 7b). which were not detected in over 100 control chromosomes.
A splice site mutation, G>C, was detected in family X03 at position +1 in intron 2. The 
first nucleotide o f a donor splice sequence is generally 100% conserved (Horowitz and 
Krainer 1994). hence the transition identified at this site is very likely to affect RNA 
splicing.
One missense mutation was identified in 2 families (X01 and X07), which results in an 
asparagine to serine change at amino acid 216 in the seventh LRR. This mutation was 
also identified in one family from Canada (Bech-Hansen, Naylor et al. 2000) and appears 
to involve a conserved residue within the LRR repeats of nyctalopin. In family X08 a 
nonsense mutation was detected resulting in protein truncation at amino acid 299 with 
loss of the eleventh LRR, the C-terminal cysteine rich LRR and GPI-anchor. Loss of the 
GPI-anchor is also the predicted result o f a 1 base pair (bp) deletion in family X I5 and 
therefore emphasises the crucial role of the GPI-anchor for nyctalopin function.
Several deletions were detected, including an in-frame 15 bp deletion in families X04 
and X06, resulting in the loss of 5 amino acids (glutamate, leucine, arginine, leucine and 
alanine) from the third LRR and therefore a smaller protein (477 amino acids). This
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mutation is predicted to alter the structure of the protein and has also been identified in 
one other family (Pusch, Zeitz et al. 2000). A 17 bp deletion was found in family X I3, 
which produces a frameshift, predicted to create 91 novel amino acids and a premature 
stop codon. The third deletion identified in three families (X05, X09 and X I4) was a 335 
bp deletion causing disruption of the C-terminal cysteine rich LRR and loss o f the GPI- 
anchor (Hardcastle. David-Gray et al. 1997; Pusch, Zeitz et al. 2000), this deletion was 
shown to segregate with the disorder in the pedigrees concerned. No polymorphisms 
were detected in the ATX gene.
To evaluate the possibility o f a founder effect among the families sharing the same 
mutations (families X05, X09 and X014, families X04 and X06 and families X01 and 
X07) microsatellite markers were amplified to create a haplotype around the ATX gene. 
Markers DXS574. DXS993, DXS8012 and DXS1201 were amplified in affected males 
from the families, as previously described (Hardcastle, David-Gray et al. 1997), to reveal 
a common haplotype in families X05, X09 and X I4 suggesting that the 335 bp deletion 
of ATX occurred as a single event in a common ancestor. The other families analysed 
appeared to be unrelated as no common haplotype was observed in families with the 
same mutation. Previous ATX gene screens also revealed recurring mutations, most 
notably a 24 bp deletion identified in 7 families (Bech-Hansen, Naylor et al. 2000).
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Table 7b: NYX gene sequence changes identified in subjects with CSNB
Pedigree Exon Sequence change* Codon change Type
X03 2 37+1G—»C Splicing
Mutation (Novel)
X13 3a 48-64, 17bp 
deletion
Frameshift 
(stop) (Novel)
X04
X06
3a 339-353, 15bp 
deletion
Amino acid 
deletion
X01
X07
3b 647A->G N216S Amino acid 
substitution
X08 3c 895C-GT Q299X Stop (Novel)
X05
X09
X14
3c-d 1122-1457, 335-bp 
deletion
Protein
truncation
(Novel)
X15 3d 1309delC L437delC Frameshift 
Stop (Novel)
* position 1 at ATG start site according to AJ278865
7.3 Summary of molecular genetic analysis
Mutation screening o f CACNA IF  and N YX  genes identified a causative mutation in 14 of 
the 15 families studied. One novel mutation in the CACNA1F gene and five novel 
mutations in the N YX  gene have been identified in addition to confirming five previously 
reported mutations in these genes. In one definitely X-linked pedigree (X02) a mutation 
was not identified on sequencing. As a result of the mutation screening the XLCSNB 
subjects were classified by genotype into two groups: subjects with identified NYX  gene 
mutations (CSNB1; pedigrees X01, X03-X09) and subjects with CACNA IF  gene 
mutations (CSNB2; pedigrees X10-X12).
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Figure 7a: CACNA1F sequencing results
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Figure 7b: Enzyme digestion confirmation of novel mutation in exon 7 - pedigree X10
Bse Rl cleaves DNA at a site containing the 
base pair (bp) sequence GAGGAG.
A. Bse Rl digestion of wildtype exon 7
BseRI site 
(GAGGAG)
60bp 170bp
Bse Rl digestion produces a 170 bp fragment 
and a 60bp fragment in the normal sequence
B. Bse Rl digestion of mutant exon 7
Loss of Bse Rl site 
(GAGTAG)
♦ ♦
230bp
Bse Rl digestion produces a single 230bp 
product due to the disruption of the cutting site
III-2
&
I V - 1 I I I -2  IV -2
IV-2
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Figure 7c: Enzyme digest confirmation of exon 48 
polymorphism -  pedigrees X04 and X05
Hph I cleaves DNA at sites with the nucleotide 
pattern GGTGAnnnnnnn-n’.
A. Hph I digestion of wildtype exon 48
♦ ♦
265bp
Wildtype exon 48 does not contain this cutting site, a 
265bp fragment results from digestion.
B. Hph I digestion of exon 48 polymorphism
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Figure 7d: Screening of controls for exon 48 sequence change
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Chapter 8 Clinical examination results
Mutation screening o f the genes C A C N A 1 F  and N Y X  (Chapter 7) enabled the genotypic 
classification o f the XLCSNB subjects in this study into genotype groups CSNB1 { N Y X  
gene mutation) and CSNB2 (C A C N A 1 F  gene mutation). The X-linked family without 
detected mutations (X02) have been excluded from clinical comparison. Subjects from 
two pedigrees with N Y X  mutations (XI 3& X I4) were unable to attend either centre for 
clinical, electrophysiological or psychophysical assessment. The only affected male from 
pedigree X I5 available to take part in the study had a history of bilateral retinal 
detachments. Since this pathology would be expected to influence his clinical test results, 
he was excluded from the phenotype study. In total 20 patients from the 11 remaining 
pedigrees were assessed clinically, 14 in the 8 pedigrees with the CSNB1 genotype and 6 
in the 3 pedigrees with the CSNB2 genotype. Pedigrees X01, X03-X09 were in the 
CSNB1 genotype group and pedigrees X10-X12 were in the CSNB2 group.
8.1 Visual acuity
Symptomatically, although the night blindness had remained stationary with age, the 
visual acuity had deteriorated in several subjects, both in the CSNB1 genotype group: 
one subject (pedigree X 03 II-9) had severe visual field loss due to glaucoma, another 
(pedigree X08 III-l) had developed myopic macular degeneration and had required laser 
therapy. Corrected visual acuity in each eye and with both eyes open was recorded 
(Table 8a.). In both the CSNB1 and CSNB2 groups the mean logMAR score was 0.4+/- 
0.2 units (6/18 equivalent). Figure 8a illustrates a scatterplot and error bar chart of the 
best binocular corrected visual acuity. Six subjects (32%) had had significant amblyopia 
(difference in visual acuity o f > 0.2 logMAR units between eyes) since childhood. Two 
subjects had suffered reduced visual acuity as adults: Subject II-9 from pedigree X03 had 
developed glaucoma for which he had had bilateral trabeculectomies, subject III-l from 
pedigree X08 had developed myopic macular degeneration with staphyloma formation 
and had required macular laser therapy.
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8.2 Refractive Error
All 20 subjects were myopic, the mean spherical equivalent ranging from -2DS to -  
18.5DS. Mean refractive error in the CSNB1 group was -7.25+/-4.5DS and in the 
CSNB2 group was -8.0+/-1.5DS (Figure 8b&c). The astigmatic element o f the refractive 
error is illustrated in Figure 8c. The mean axial lengths were 26.9+/-1.4mm in the 
CSNB1 group and 27.9+/-0.4mm in the CSNB2 group, confirming the myopia to be 
axial rather than refractive.
8.3 Nystagmus and strabismus
Nystagmus was present in 15 o f the 20 subjects (75%) and was o f similar type 
(horizontal) in the CSNB1 and CSNB2 groups, the amplitude o f nystagmus tended to be 
larger in subjects with the worse visual acuity. The four patients who did not have 
detectable nystagmus had a binocular logMAR visual acuity of 0.1-0.2 (6/9).
Strabismus was present in 18 o f the 20 subjects (90%). Three subjects had undergone 
strabismus surgery in childhood (pre-operative deviation is shown in Table 8a). All 
subjects in the CSNB2 group were esotropic whereas 8 o f the 14 subjects (57%) in the 
CSNB1 group were esotropic and 4 (29%) were exotropic. Two subjects (14%) in this 
group were orthophoric without strabismus surgery (Figure 8d).
Figure 8a: Scatterplot of best corrected binocular visual acuity (logMAR) 
between genotypes
9_i
GROUP
" CSNB2 
c CSNB1
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Figure 8b: Scatterplot of mean spherical 
equivalent between genotypes
GROUP
CSNB2
CSNB1
Figure 8c: Refractive error 
(each axis represents a 
retinoscopic axis)
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Figure 8d: Comparison of strabismus types between genotype groups
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8.4 Slit lamp examination (SLE)
8.4.1 Anterior segment examination
17 of the 20 subjects had normal anterior segment appearance on SLE (Table 8b). One 
subject had iris translucency (IV-9 from pedigree X03). Subject II-9 from pedigree X03 
had features consistent with previous bilateral trabeculectomies. Another had evidence of 
previous anterior uveitis (III-3 from pedigree X10).
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8.4.2 Fundoscopy
18 o f the 20 patients (89%) had tilted optic nerve heads and, o f these, most had a tigroid, 
hypopigmented fundus inferotemporally. Two patients, both in the CSNB1 group and 
low myopes did not have these features o f myopia. There was no apparent difference in 
the fundal appearance o f subjects in the CSNB1 and CSNB2 groups (Figure 8e)
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Table 8a: Clinical examination of CSNBX subjects
CSNB1 Subject Age LogMar
Pedigree OD OS
Snellen Nystagmus Strabismus Mean Sph 
luiv.
Mean Axial
X01 IV-2 16 0.2 0.3 0.1 6/9 None 40PD ET -2.75 25.45
X03 II-9 75 0.5 0.6 0.5 6/18 Fine, horiz OT -1.25
11-11 67 0.5 1 0.4 6/18 Fine, horiz OT -3.5 26.02
IV-9 36 1 0.3 0.3 6/12 Fine, horiz 20PD ET -8.25 27.13
IV-17 17 0.4 1 0.4 6/18 Fine, horiz 20PD ET -9.25
X04 IV-2 30 0.8 1 0.5 6/18 Fine, horiz 40PD ET -10.25 28.43
X05 V-2 54 0.5 0.6 0.4 6/18 Fine, horiz 40PD XT -4.25 26.12
VI-6 24 0.4 0.8 0.4 6/18 Fine, horiz 40PD ET -16.75 28.54
VI-7 21 1 0.8 0.7 6/36 Coarse, horiz 40PD ET -12.00 28.10
X06 III-5 62 0.5 0.2 0.2 6/9 None 20PD ET -2.0 25.13
X07 III-l 48 0.2 0.6 0.2 6/9 Fine, horiz 35PD ET -6.5 27.85
X08 III-l 40 1 1 1 6/60 Fine, horiz 40PD XT -12.25 28.21
IV-2 11 0.2 0.8 0.2 6/9 None 15PD XT -8.25
X09 IV-6 63 0.3 0.2 0.2 6/9 None 15PD XT -3.0 25.32
CSNB2
pedigree
X10 III-3 51 0.8 0.6 0.6 6/24 Coarse, horiz 20PD ET -9.0 28.14
IV-8 26 0.6 0.6 0.5 6/18 Coarse, horiz 15PD ET -5.0
X ll III-3 79 0.7 0.6 0.6 6/24 Coarse, horiz 15PD ET -8.5
IV-2 17 0.4 0.3 0.3 6/12 Fine,horiz 15PD ET -9.75 27.65
IV-5 8 0.5 0.3 0.3 6/12 Fine, horiz 20PD ET -7.75
X12 IV-2 11 0.2 0.2 0.2 6/9 None 15PD ET -8.5
PD=prism dioptres
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Table 8b Slit lamp examination features of XLCSNB subjects
CSNB1
Pedigree
Subject Age Iris translucency Optic disc 
tilt
Fundal 
>onij
Other
X01 IV-2 16 No No No
X03 II-9 75 No Yes Infero-temporal Glaucomatous disc cupping L>R
11-11 67 No Yes Infero-temporal
IV-9 36 Yes Yes Infero-temporal
IV-17 17 No Yes Infero-temporal
X04 IV-2 30 No Yes Infero-temporal
X05 V-2 54 No Yes Macula and IT
VI-6 24 No Yes Macula and IT
VI-7 21 No Yes Macula and IT
X06 III-5 62 No Yes Infero-temporal
X07 III-l 48 No Yes Inferotemporal
X08 III-l 40 No Yes Inferotemporal Bilateral staphylomata, laser scars
IV-2 11 No Yes No
X09 IV-6 63 No No No Mild atrophic macular change
CSNB2
pedigree
X10 III-3 51 No Yes Infero-temporal Bilateral cataracts
IV-8 26 No Yes No
X ll III-3 79 No Yes Infero-temporal
IV-2 17 No Yes Infero-temporal
IV-5 8 No Yes No
X12 IV-2 11 No Yes Infero-temporal
IT=infero-temporal
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Figure 8e: Fundus appearance
CSNB1 (NYX mutation)
X03 IV-9 X09 IV-6
X04 IV-2
X08 IV-2
CSNB2 (CACNA1F mutation)
X10 III-3
X11 IV-2
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Chapter 9 Psychophysics results
9.1 Colour vision
A summary o f the colour vision testing results in shown in Table 9a. No specific colour 
vision abnormalities detected in the majority of subjects. The subjects with the more 
severe colour abnormalities had other pathology that might explain this. Subject X03 II- 
9 had glaucomatous optic disc cupping, Subject X05 V-2 had bilateral macular 
staphylomata, Subject X08 III-l had bilateral myopic maculopathy previously treated 
with focal laser therapy.
9.2 Photopic Perimetry
Photopic perimetry identified normal or near normal foveal sensitivities but a gradual 
reduction in sensitivity with eccentricity from the fovea in most subjects (Figure 9a). 
Central sensitivities were reduced in the subject with myopic maculopathy (X08 III-l) 
and extensive visual field loss was present in the subject with glaucomatous disc 
cupping (X03 II-9). There was no evidence o f visual field constriction or mid-peripheral 
scotomata.
9.3 Scotopic Perimetry
Scotopic static perimetry was performed on 9 adult subjects, 7 in the CSNB1 group and 
2 in the CSNB2 group according to the protocol (Chapter 6.5.1). Examples of the results 
are shown in Figure 9b. The first graph is a grey scale representation of scotopic 
sensitivity. Normal values when the short wavelength, blue stimulus is used is 46dB or 
a clear grey scale (10dB=l log unit) and for the long wavelength, red stimulus, 34dB or 
a lightly stippled gray scale. Mean sensitivity measurement was calculated by averaging 
the values measured at retinal locations -9,+9 and +9,-9 on the HFA grid.. The range of 
mean threshold elevation in subjects with N YX  mutations (CSNB1) was 2.5-4.4 (mean 
3.5) log units with the blue and 1.6-3.1(mean 2.0) log units with the red stimulus. 
Subjects with CACNA1F  mutations (CSNB2) showed a range of mean threshold
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elevation o f 1.3-2.3 (mean 2.0) log units for the blue and 1.8-1.9 (mean 1.9) log units 
for the red stimulus. In every subject there was a relative reduction in sensitivity in the 
superior visual field, i.e. the inferior retina, of up to 1 log unit compared to the inferior 
field.
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Table 9a: Results of colour vision assessment
CSNBl
Pedigree
Subject Ishihara City University HRR test M-R Minimalist 
Normal = P1,D1,T1
Cambridge Colour 
TestNormal=
P<100, D<100, T<150
X01 IV-2 Normal Normal Normal Normal Normal
X03 11-9 Missed most R-G plates Normal Missed most R-G plates 
Normal
P3,D4, T1 N/A
11-11 Normal Normal Normal Normal N/A
1V-9 Normal Normal Normal Normal Normal
IV -17 Normal Normal Normal Normal
X04 IV-2 Missed most R-G plates Normal Missed most R-G plates P1,D3,T2 P266,D448,T164
X05 V-2 Missed most R-G plates 3 R-G plates incorrect 
Normal
Missed all R-G and 
B-Y plates
P2,D3,T1 PI 100, D1100,T1100 
Normal
VI-6 Normal Normal Normal Normal Normal
VI-7 Normal Normal Normal
X06 II1-5 Normal Normal Normal Normal Normal
X07 III-l Normal Normal Normal P1,D1,T3 N/A
X08 III-l Normal Normal Missed most R-G plates 
Normal
P6,D6,T2 N/A
IV-2 Normal Normal P3,D2,T2 P311,D100,T153
X09 IV-6 Normal Normal Normal Normal P232,D219,T204
CSNB2
Pedigree
X10 III-3 Normal Normal Missed most B-Y plates 
Normal
Normal P163,D154,T322
IV-8 Normal Normal Normal N/A
X ll 111-3 Normal Normal Normal Normal N/A
IV-2 Normal Normal Normal Normal N/A
IV-5 Normal Normal Normal Normal N/A
X12 IV-2 Normal Normal Normal Normal N/A
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Figure 9a: Photopic perimetry from representative subjects. Photopic perimetry identified a gradual reduction in sensitivity with 
eccentricity from the fovea in most subjects from each genotype group.
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9.4 Dark adaptometry
Dark adaptation was tested in two retinal locations using a red stimulus (650nm) and a 
blue stimulus (450nm) as stated in the protocol (Chapter 6.5.2). Representative dark 
adaptation curves for these four stimulus conditions are illustrated in Figure 9c. Due to 
differences in technique, the absolute values differ from the scotopic static perimetry 
determinations, therefore all results are reported as relative to corresponding normal 
values.
The control curve in Figure 9c demonstrates the threshold intensity for the blue and red 
stimulus at the two retinal locations tested. The threshold increases by approximately 
41og units following the bleach and a blue stimulus rod/cone break occurs after 
approximately 9 minutes o f dark adaptation. Pre-bleach threshold measurements are 
reached after approximately 30-40 minutes of dark adaptation.
9.4.1 Dark adaptometry in subjects with NYX  mutations (CSNB1)
The mean absolute threshold for the two retinal test locations was elevated by 2.4 - 4.3 
log units for the blue stimulus and by 1.9 - 3.2 log units for the red stimulus compared 
to control values. Four o f the seven CSNB1 subjects tested showed definite rod/cone 
breaks for the blue stimulus, occurring after approximately 9 minutes o f dark 
adaptation, the other curves were unreliable. The dark adaptation curves are plotted 
together for the blue stimulus tested at retinal location -9,9 (Figure 9d(i)). All CSNB1 
subjects reached their pre-bleach thresholds by 30 minutes and demonstrated normal 
adaptation kinetics.
9.4.2 Dark adaptometry in subjects with CACNA1F mutations (CSNB2)
Two subjects with CSNB2 underwent dark adaptometry. The blue stimulus absolute 
threshold was elevated by 0.6 - 1.5 logunits and the red stimulus absolute threshold by 
0.7 - 1.8 log units compared to controls. Although 1 o f the 2 CSNB2 subjects 
demonstrated a rod/cone break (Figure 9d(ii)), subject X I0 III-3 showed a monphasic 
curve with increased sensitivity compared to the control. This subject had bilateral 
cataracts which presumably prevented a complete bleach prior to testing. Both CSNB2 
subjects reached their pre-bleach thresholds by 30 minutes and demonstrated normal 
dark adaptation kinetics.
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Figure 9c: Dark adaptation curves: red and blue stimuli, retinal locations-9 ,9 , 9,-9. Rod/cone breaks were demonstrated in 
subjects from each genotype groups to the blue stimulus only.
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Figure 9d: Dark adaptation curves: Blue stimulus, retinal location -9 ,9
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9.5 Spectral sensitivity curves
Four CSNB1 subjects and 2 CSNB2 subjects underwent assessment of spectral 
sensitivity. Spectral sensitivities to the 5 different wavelengths ( 450nm, 488nm, 590nm 
and 633nm) were calculated and plotted for the two retinal locations tested (Figure 9e). 
The CIE scotopic sensitivity curve shown in Figure 9e has been shifted downwards on 
the y-axis to enable comparison of curve shape with the XLCSNB subjects tested. The 
spectral sensitivity curves of all subjects in each genotype group fitted the CIE curve 
with no apparent shift in peak sensitivity towards longer wavelengths.
Figure 9e: Spectral sensitivity curves for retinal position 9,-9.
   1----------------
488 520 590
W avelength (nm)
 >D9 IV-6
XD5 VI-6 
XD4 IV-2
 X10 III-3
 XD3IV-9
 X10 IV-8
 Control 1
 Control 2
CIE scotopic sensitivity curve
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Chapter 10 Electrophysiology
ISCEV standard ERGs were performed in the manner described in Chapter 6. Eleven 
pedigrees had previously been identified as having an N YX  gene mutation (Chapter 8). 
Eleven affected male subjects from 8 o f these 11 pedigrees were assessed 
electrophysiologically using foil electrodes. One pedigree (X I5) was excluded due to 
the subject’s history o f bilateral retinal detachments. Affected members from 2 
pedigrees were unavailable for testing. Four affected males from the 3 pedigrees with 
identified CACNA1F  gene mutations were also assessed. Where possible scotopic 
threshold responses, ON-OFF responses and visual evoked potentials were also 
performed. Skin disc electrodes were used for one child in each genotype group and 
these results have not been included. An overview of representative ERG waveforms for 
a control, a CSNB1 subject (N Y X gene mutation) and a CSNB2 subject (CACNA1F 
gene mutation) is shown in Figure 10a. The small sample size of each group limits the 
use of quantitative statistics in the analysis of the following data, therefore descriptive 
statistical methods have been used to compare group results. Electrophysiological 
results are reported as abnormal if the value was above or below the 95% upper and 
lower confidence limit o f the control group respectively.
10.1 Rod mediated responses
10.1.1 The scotopic threshold response (STR)
Representative STR recordings are shown for the three subject groups in Figure 10b(i). 
The STR was present in all 10 control subjects but was unrecordable in 5 of the 10 
CSNB1 subjects tested and 1 o f the 2 CSNB2 subjects tested. The intensity of flash 
required to produce the STR tended to be higher in subjects with XLCSNB than in 
controls (Figure 10b(ii)): the mean minimum flash intensity required for the response 
was SF-6.9 log units in controls and SF-5.3 log units in XLCSNB subjects. The 
intensity o f the stimulus required to produce the maximum response was comparable in 
the subject groups. The maximum STR amplitudes tended to be larger in control 
subjects than XLCSNB subjects (Figure 10b(iv)). The latency of the response was 
delayed in 4 o f the 5 CSNB1 subjects and 1 CSNB2 subject.
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Figure 10a: Comparison of ERG waveforms 
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Figure 10b: The scotopic threshold response 
i) Representative STR waveforms
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10.1.2 The scotopic ERG
The scotopic ERG was measured to three different intensities of stimulus: Standard 
Flash (SF)- 4 log units, SF-2.6 log units and SF-1 log unit. The a-wave becomes 
measurable at SF-1 log unit flash intensity. The characteristics of the b-wave are most 
accurately assessed in these scotopic conditions where the a-wave is not a complicating 
feature o f the waveform. Representative responses to ISCEV standard scotopic 
stimulation (SF-2.6 log unit filter) are shown in Figure 10c(i).
Scotopic ERG responses are summarised in Table lOa.The a- and b-wave latency for 
each stimulus intensity results were normal in both genotype groups. The b-wave 
amplitude was subnormal in all XLCSNB subjects for each stimulus intensity (Figure 
10c(ii)). A response to the ISCEV standard scotopic stimulus (SF -2.6 log units) was 
detected in 9 o f the 11 (82%) CSNB1 subjects and 3 o f the 4 (75%) CSNB2 subjects. 
The mean b-wave amplitude did not appear to differ markedly between genotypes.
Summary
• a- and b-wave latencies were generally normal in both forms of CSNB
• A b-wave response to the standard ISCEV scotopic stimulus (SF -2.61ogunits) 
was present in the majority o f XLCSNB subjects from each genotype group.
• The b-wave response was subnormal in all subjects with CSNB.
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Table 10a: Table of scotopic ERG properties
Stimulus
intensity
Property Control
(n=19)
NYX mutation
group
(n = ll)
CACNA1F mutation 
group ( n=4)
SF-41u b-wave amplitude (uV)
Response recorded in N° (%)
78+/-29
19(100%)
3+/-5 
3 (27%)
11+/-7 
3 (75%)
SF-2.61u b-wave amplitude (uV)
Response recorded in N° (%)
261+/-66
19(100%)
17+/-13 
9(82%)
49+/-39
3(75%)
SF a-wave amplitude (uV) -315+/-60 -307+/-84 -268+/-43
Response subnormal in N° (%) 0 2(18% ) 0
b-wave amplitude (uV) 472+/-85 190+/-5 7 204+/-51
Response subnormal in N° (%) 0 11 (100%) 4(100% )
Maximal OP amplitude (uV) 62+/-25 0 26+/-8
Response subnormal in N° (%) 0 11 (100%) 0
b-wave:a-wave ratio 1.5+/-0.2 0.6+/-0.1 0.8+/-0.1
lu=log units 
uV=microvolts
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Figure 10c: Rod mediated ERG results (dark adapted eye)
i)Representative rod ERGs 
(SF-2.6lu).
Note differing scales and 
lower amplitude responses 
in both XLCSNB groups.
Control
CSNB1
CSNB2
iOuV
100m s
ii) B-wave amplitude scatterplots. Subnormal b-wave amplitudes are illustrated in both 
genotype groups, the CSNB1 subjects (NYX mutations) having the most attenuated 
response.
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10.1.3 The Dark Adapted Standard Flash ERG
Representative responses are shown in Figure 10d(i). All affected subjects demonstrated 
the ‘negative wave’ ERG which characterises the Schubert-Bomschein form of CSNB. 
The a- and b-wave latency measurements between the subject groups were normal in 
both genotype groups. There was overlap in a-wave amplitudes between the subject 
groups, two o f the 11 (18%) CSNB1 subjects had subnormal a-wave amplitudes.
The b-wave amplitudes were subnormal in the XLCSNB subjects but were comparable 
between genotypes (Figure 10d(ii)).
Summary
• The a-wave amplitude was subnormal in 2 o f the 11 NYX  mutation subjects
• The b-wave amplitudes in all subjects with XLCSNB were subnormal but 
comparable between genotype groups
10.1.4 Scotopic oscillatory potentials
Representative OP waveforms are shown in Figure 10e(i). The 4 expected OP peaks 
were identified in all control subjects, several OP peaks were identified in the subjects 
with CSNB2 but no measurable response was detected in any of the 11 subjects in the 
CSNB1 genotype group. The absence o f several OP peaks in the CSNB2 group made 
assignment of the peak number difficult, therefore the maximal OP peak amplitude was 
measured and compared to the maximal OP peak (OP1 or 2) in the control group and 
peak latencies were not compared. The results are illustrated in Figure 10e(ii).
Summary
• Scotopic OP responses were abnormal in all CSNBX subjects
• Subjects with CACNA1F mutations demonstrated only 2 of the expected 4 OP 
peaks
• No measurable scotopic OP response was seen in any subject with a NYX  
mutation
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Figure 10d: Dark adapted Standard Flash ERG results
i) Representative waveforms.
Note the “negative” waveform in 
XLCSNB and the smooth contour Control 
of the ascending limb of the b-wave 
in CSNB1 (NYX mutation).
CSNB1
CSNB2
200uV
100ms
ii) B-wave amplitude scatterplot and error bar chart. Subnormal b-wave amplitude 
are illustrated in both XLCSNB groups to this stimulus, the mean response being similar in 
both genotype groups.
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Figure 10e: Oscillatory potentials
OP1
i): Representative scotopic 
OPs. Note the absence of a 
recordable OP waveform in CSNB1 
(NYX mutation) and the abnormal 
waveform in CSNB2.
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CSNB1
CSNB2
20uV
•P4
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ii) Maximum OP amplitude scatterplot and error bar chart. The OP response 
was unrecordable in all 11 subjects in the CSNB1 group and the maximum OP 
amplitude subnormal in subjects in the CSNB2 group.
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10.2 The cone mediated ERG
Cone mediated responses were tested using two different conditions: firstly by using a 
red coloured stimulus in the dark adapted eye and secondly using the SF stimulus 
against a rod saturating light background in the light adapted eye. Representative cone 
derived responses to a SF stimulus in light adapted conditions are shown in Figure
m i) .
The a-wave latencies in photopic conditions using the SF stimulus were prolonged in all 
11 subjects with CSNB1 (Table 10b, figure 10f(ii)). These findings were confirmed 
with the red stimulus. B-wave latency was prolonged in 4 of the 11 (36%) CSNB1 
subjects and only 1 o f the 4 (25%) CSNB2 subjects.
The calculated mean a-wave amplitudes in the subject groups were similar when the red 
stimulus was used. In photopic conditions, 3 of the 4 (75%) CSNB2 subjects and 1 of 
the 11 (9%) CSNB1 subjects had subnormal a-wave amplitudes (Figure lOe(iii)). The 
results o f b-wave amplitude comparison between the subject groups were different 
depending on the test condition used. Scotopic stimulation with a red stimulus resulted 
in subnormal b-wave amplitude measurements in all XLCSNB individuals. Use of the 
photopic SF stimulus resulted in subnormal b-wave responses in all CSNB2 subjects 
(Figure 10f(iv)). The mean b-wave amplitude in the CSNB2 group was lower than that 
of the control or CSNB1 group(Table 10b).
Summary
• The a-wave latency was prolonged in all subjects with NYX  mutations
• The b-wave latency was prolonged in subjects from each XLCSNB genotype 
group.
• The majority of subjects with CACNA1F mutations had a subnormal photopic a- 
wave amplitude
• The photopic b-wave amplitude was subnormal in all subjects with CACNA1F 
mutations
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Table 10b: Table of photopic ERG properties
Stimulus Property Control NYX  mutation CA CNA1F  mutation
(n=19) group (n=l 1) group (n=4)
SF Mean a-wave latency (ms) 13+/-6 16+/-1 16+/-1
Response prolonged in N° (%) 0 11 (100%) 3 (75%)
Mean a-wave amplitude (uV) -62+/-15 -66+/-18 -38+/-20
Response subnormal in N° (%) 0 0 2 (50%)
Mean b-wave amplitude (uV) 129+/-41 100+/-30 46+/-15
Response abnormal in N° (%) 0 0 2(50%)
30Hz Flicker Mean latency (ms) 11+/-2 15+/-5 15+/-3
Response prolonged in N° (%) 0 8(73%) 1 of 2 recordable (50%)
Mean amplitude (uV) 96+/-28 84+/-23 25+/-13
Response subnormal in N° (%) 0 0 2of 2 recordable (100%)
ON-OFF response Control NYX CACNA1F
(n=15) (n=2) (n=2)
Mean a-wave latency (ms) 22+/-1 28+/-5 31+/-2
Response prolonged in N° (%) 0 2(100%) 2(100%)
Mean a-wave amplitude (uV) -36+/-8 -32+/-0 -17+/-7
Response subnormal in N° (%) 0 0 1(50%)
Mean b-wave amplitude (uV) 67+/-14 19+/-9 18+/-2
Response subnormal in N° (%) 0 2(100%) 2(100%)
Mean d-wave amplitude (uV) 49+/-16 52+/-24 16+/-1
Response subnormal in N° (%) 0 0 2(100%)
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Figure 10f: Cone mediated ERG results. 
^Representative cone ERGs.
Note differing scales and 
lower amplitude CSNB2 
response.(Standard Flash, 
light adapted eye)
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CSNB2
100ms
J“ 100uV
poouv
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ii) A-wave latency scatterplots and error bar charts. The 
latency was prolonged in all CSNB1 subjects (NYX mutations) and 
the majority of CSNB2 subjects (CACNA1F mutations).
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Figure 10f: Cone mediated ERG results -  continued
iii) A-wave amplitude scatterplots and error bar charts. The majority of subjects 
(75%) in CSNB2 group (CACNA1F mutations) had subnormal photopic a-wave amplitudes.
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Dark adapted red flash stimulus. B-wave amplitudes were subnormal in all subjects 
with XLCSNB.
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10.3 b-wave to a-wave ratio
The characteristic ‘negative’ waveform ERG results in a b-wave to a-wave ratio less 
than unity. The b-wave to a-wave ratio was less than one in every XLCSNB subject 
when the SF stimulus in the dark adapted eye testing condition was used (Figure 
10g(i)). The mean ratio was slightly lower in the CSNB1 group than the CSNB2 group 
(CSNB1: 0.6+/-0.1, CSNB2: 0.8+/-0.1, control: 1.5+/-0.2).
Under photopic conditions there was more overlap in the ratio range between groups 
(Figure 10g(ii)). Three subjects demonstrated a ratio less than one, one in each group. 
The mean ratio was lower in the two XLCSNB groups than in controls (CSNB1: 1.6+/- 
0.3, CSNB2: 1.3+/-0.4, Control: 2.0+/-0.7).
Summary
• The scotopic b-wave: a-wave ratio was less than one in every subject with 
XLCSNB
• The mean scotopic ratio was lower in the N YX  mutation group than the 
CA CNA1F  mutation group
• The photopic mean ratio was above one in both genotype groups
10.4 30Hz flicker response
Representative light adapted 30 Hz flicker responses are illustrated Figure 10h(i). Most 
subjects became photophobic during this test and the response was unrecordable above 
muscle artifact in 2 of the 4 subjects in the CSNB2 group. Although the calculated 
group means were similar, 8 of the 11 (73%) CSNB1 and 1 of the 2 (50%) CSNB2 
subjects had prolonged 30Hz latencies (Figure 10h(ii)). The waveform of the response 
in subjects from both genotype groups was abnormal: the CSNB1 waveform was 
lacking the OP influence on the ascending limb of the response seen in controls, giving 
a saw-tooth appearance, and the response from subjects with CSNB2 was double 
peaked. The two members o f the CSNB2 group in whom testing was possible had 
subnormal amplitude values (Figure lOh(iii)).
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Summary
• The 30Hz waveform was abnormal in the two XLCSNB groups and appeared 
specific to genotype
• The latency appeared prolonged in the majority of subjects with NYX  mutations
• The response amplitude was subnormal in both subjects with CACNA1F 
mutations tested
• The mean response amplitude in the NYX  mutation group was comparable to the 
control group
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Figure 10g: B-wave to a-wave ratios
i) Dark adapted b-wave:a-wave ratio scatterplot and error bar chart. 
The b/a-wave ratio was less than one in every XLCSNB subject, and the mean 
ratio was lower in the CSNB1 (NYX mutation) group.
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ii) Light adapted b-wave:a-wave ratio scatterplot and error bar chart. The 
photopic b/a-wave ratio was over one in all subjects with XLCSNB. The mean ratio was 
lower in the CSNB2 group (CACNA1F mutations).
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Figure 10h: 30 Hertz flicker results
i) Representative 30 Hz 
flicker responses. Note the 
“saw-tooth” waveform of 
CSNB1 subjects and the 
double peaked, low amplitude 
waveform of CSNB2 subjects.
Control
CSNB1
CSNB2
100uV
100uV
I5uV
ii) 30 Hz flicker latency scatterplot and error bar chart. The 30Hz 
flicker latency was prolonged in the majority of subjects from each group 
although the mean group latencies were comparable.
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iii) 30 Hz flicker amplitude scatterplot and error bar chart. The 
response amplitude was subnormal in both CSNB2 patients (CACNA1F 
mutation).
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10.5 ON-OFF response
Representative ON-OFF responses are shown in Figure 10i(i). The test was performed 
on 16 controls and 2 subjects from each XLCSNB genotype group.
The a-wave latencies of the cone mediated response with a long ON stimulus were 
prolonged in all subjects in the XLCSNB groups (Figure 10i(ii)). The b-wave latency 
was prolonged in 1 of the 2 subjects with CSNB1. The d-wave latency was delayed in 
both subjects with CSNB2.
The a-wave amplitude was subnormal in one control and one of the 2 subjects with 
CSNB2. The b-wave amplitude was subnormal in all XLCSNB subjects. The d-wave 
amplitude was subnormal in both subjects with CSNB2 (Figure lOi(iii)).
Summary
• Subjects from both genotype groups had prolonged a-wave latencies
• Subjects with N YX  gene mutations had prolonged b-wave latencies and 
borderline prolonged d-wave latencies
• Subjects with CACNA1F mutations had prolonged d-wave latencies
• The b-wave amplitude was subnormal in all subjects with XLCSNB
• The d-wave amplitude was subnormal in subjects with CACNA1F mutations
10.6 Photopic negative Response (PhNR)
This response was calculated from two test conditions: the light adapted SF ERG 
response and the ON-OFF response. This response is the component which follows the 
b-wave peak and is thought to correlate with inner retinal activity (Chapter 2).
The amplitude of the PhNR measured with the SF stimulus was subnormal in 8 of the 
11 (73%) subjects with CSNB1 and all subjects with CSNB2. The mean amplitude was 
lower in these two subject groups than in the control group (Figure 10j(i)). The reduced 
PhNR amplitude was confirmed by the results using the ON-OFF (i.e. long flash 
stimulus) response conditions (Figure 10j(ii)).
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Summary
• The PhNR was subnormal in the majority of XLCSNB subjects
• The PhNR to b-wave amplitude ratio was lower in XLCSNB subjects than in 
controls
Figure 10i: ON-OFF response
^Representative ON-OFF 
responses 
Note the reduced d-wave 
amplitude in the 
CSNB2 subject 
PhNR=photopic negative 
response 
d=dwave (OFFresponse)
108uV
PhNRControl
108uV
CSNB1
64 uV
CSNB2
300m s150ms
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Figure 10i(ii): ON-OFF response Scatterplots of a-, b and d-wave latencies. The latencies were prolonged 
in the majority of XLCSNB subjects. :
a-wave b-wave d-wave
GROUP GROUP
Control
iii) Scatterplots of a-, b- and d-wave amplitudes.b-wave amplitude was subnormal in all XLCSNB subjects, the d-wave was 
subnormal in both CSNB2 (CACNA1F mutation) subjects.
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Figure 1 0 j :  Photopic negative response
i) PhNR to SF stimulus scatterplot and error bar chart
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ii) PhNR to long flash stimulus scatterplot and error bar chart
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10.7 Visual Evoked Potential
Figure 10k illustrates the differential potentials (difference response) for stimulation of 
each eye in the population of controls and the CSNB1 and CSNB2 subjects.
None o f the controls demonstrated a difference in polarity of the trace between eyes. 
However, of the 10 CSNB1 subjects tested, 2 subjects showed evidence o f definite 
asymmetry with 3 further subjects having equivocal results; 1 of the 2 subjects with 
CSNB2 also demonstrated equivocal evidence of response asymmetry. The 2 subjects in 
the CSNB1 group with asymmetry on VEP were subjects X05 VI-6 and X09 IV-6. 
These subjects’ clinical features are outlined in Table 8a&b. None o f these subjects had 
iris translucency on SLE. Infero-temporal hypopigmentation with foveal hypoplasia was 
noted in X05 VI-6 only. Two other affected members from pedigree X05 showed no 
evidence of response asymmetry.
Summary
• Asymmetry in hemispheric laterality similar to that seen in albinism appears to 
be present in some subjects with the CSNB1 genotype
• It is not consistent within pedigree and it may occur in the absence of iris 
translucency and fundal hypopigmentation
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L eyeFigure 10k: Pattern onset VEP: “difference response” left occipital-right occipital
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Chapter 11 Discussion
11.1 Molecular Genetic findings
Mutation screening o f CACNA1F and N YX  genes identified a causative mutation in 14 of 
the 15 families tested (Zito, Allen et al. 2003). Although N YX  gene mutations were much 
more prevalent than CACNAIF  gene mutations, this may be a chance finding rather than 
a true indication o f the relative proportion of genotype in the UK due to the small size of 
the sample. No mutations were found in one X-linked pedigree (X02). Since the 
phenotype of these subjects was similar to that described for subjects with NYX  
mutations, it is likely that the causative mutation in this pedigree may be present in the 
undefined promoter region, in alternatively transcribed exons or deep within the introns 
o f the N YX  gene. Alternatively the causative mutation may be in a different gene: a third 
locus for XLCSNB in Xp21.1 has been previously described in two families (Bergen, ten 
Brink et al. 1996). The affected members in these families had very poor rod-mediated 
responses and were similar in phenotype to affected members of pedigree X02. Support 
for another XLCSNB locus at Xp21.1 is given by the presence of CSNB1 phenotype 
electrophysiological changes in Xp21 deletion syndrome (Oregon Eye Disease)
(Weleber, Pillers et al. 1989; Pillers, Seltzer et al. 1993).
11.2 Clinical examination in XLCSNB
The small number o f subjects and the preponderance of pedigrees with the CSNB1 (NYX  
gene mutations) genotype compared to the CSNB2 (CACNA IF  gene mutations) limits 
the meaningful application o f quantitative statistics to the results.
There was no evidence in our patient group to suggest a progressive deterioration in 
visual function. Although several subjects had noted deterioration in visual acuity with 
age, this could be explained by concurrent pathology. There was a high degree of inter- 
and intra-familial variability in clinical phenotype but a high concordance between the 
eyes of each subject, despite the presence of amblyopia. This suggests that other genetic 
or environmental factors may influence clinical severity. Mild peripheral iris
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translucency was identified in only one CSNB1 genotype subject. This feature was not 
present in any other affected member in his pedigree and was not associated with 
features o f pigment dispersion syndrome. Although not previously reported in subjects 
with XLCSNB, iris translucency has been identified in subjects with a diagnosis of 
AIED (Witkop, Quevedo et al. 1983; van Dorp, Eriksson et al. 1985) and supports the 
speculation that these conditions are one and the same (Hawksworth, Headland et al.
1995). Optic disc tilt accompanied by infero-temporal retinal hypopigmentation was 
present in most subjects, a minority o f whom also had foveal hypoplasia. Although 
usually ascribed to high myopia, optic disc tilt and sectoral hypopigmentation was seen 
in the majority of subjects with low degrees of myopia and astigmatism, suggesting that 
it may be a characteristic o f XLCSNB itself. Infero-temporal retinal hypopigmentation 
was accompanied by a more severe reduction in scotopic threshold sensitivity in the 
supero-nasal visual field.
The clinical features and effect on visual function of XLCSNB are extremely variable 
and there appears to be no consistent clinical, psychophysical or electrophysiological 
feature that enables the distinction of Aland Island Eye Disease from CSNB2. 
Additionally, mutations in the CACNAIF gene have been identified in the majority of 
patients with a clinical diagnosis of AIED (Andrassi, Alitalo et al. 1999; Wutz, Sauer et 
al. 2002). The existence of AIED as a distinct entity seems unlikely.
11.3 “Complete” versus “incomplete” clinical forms of XLCSNB
Both genotype groups showed the typical “negative-wave” ERG configuration of 
XLCSNB due to a grossly sub-normal b-wave response. Miyake based his clinical 
classification of XLCSNB on the basis of absent rod-mediated responses in the 
“complete” form on electrophysiological and psychophysical testing (Miyake, Yagasaki 
et al. 1986). It has been postulated that the “complete” XLCSNB phenotype results from 
N YX  gene mutations and the “incomplete” XLCSNB phenotype results from CACNA1F 
gene mutations (Bech-Hansen, Naylor et al. 1998; Bech-Hansen, Naylor et al. 2000; 
Pusch, Zeitz et al. 2000). The results from this study show that rod-mediated responses 
can be recorded in both genotypic forms of XLCSNB.
The evidence for residual rod function includes:
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• Biphasic dark adapatation curves in subjects from both genotype groups
• Scotopic threshold responses recorded in both genotype groups
• Scotopic spectral sensitivity curves indicating mediation by a desensitized rod 
system in both genotype groups
• ERGs showing recordable scotopic b-wave responses in subjects from both 
genotype groups
These findings demonstrate that mutations in both the N YX  and CACNA1F genes result 
in desensitization o f the scotopic system. Although rod-mediated inner retinal responses 
tend to be more severely affected in CSNB1 as illustrated by a lower scotopic b-/a-wave 
ratio, rod-mediated responses can be identified in the majority of subjects from each 
genotype group. Although this is not the first report of detectable rod-mediated b-waves 
in subjects with N YX  gene mutations, more commonly they are described as absent in 
this genotype (Pusch, Zeitz et al. 2000; Scholl, Langrova et al. 2001). Possible 
explanations for the high detection rate in our study compared to some of the earlier 
work includes the use o f ISCEV standard stimuli with a Ganzfeld system and modem, 
sophisticated amplifying and averaging techniques in addition to differences in dark 
adaptation between laboratories. The data from this study suggests that the current 
clinical classification into “complete” and “incomplete” phenotypic forms on the basis of 
an absent scotopic response is not justified.
11.4 CSNB1 versus CSNB2
Having shown that a functioning but desensitized scotopic system is present in both 
genotypic forms o f XLCSNB, other psychophysical and electrophysiological 
characteristics can help to elucidate other differences in retinal pathophysiology between 
CSNB1 and CSNB2.
Although rod and cone photoreceptor function has previously been accepted as normal, 
recent studies, including this one, have demonstrated possible rod photoreceptor 
dysfunction in CSNB1 (NYX  gene mutations) and possible cone photoreceptor 
dysfunction in CSNB2 (CACNA1F gene mutations) (Hansen, Asefzadeh et al. 2001; 
Scholl, Langrova et al. 2001; Langrova, Gamer et al. 2002; Allen, Zito et al. 2003).
These deductions are based on a sub-normal a-wave response, which may represent a
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true abnormality in the hyperpolarization of the photoreceptor due to the molecular 
defect in each genotypic form of XLCSNB or which, since the ERG is a composite 
waveform, may be a phenomenon secondary to abnormalities of other cells in the retinal 
circuitry: OFF bipolar cell activity is known to shape the a-wave in photopic conditions 
(Sieving, Murayama et al. 1994).
The profoundly sub-normal scotopic b-wave (leading to b-/a-wave ratio less than 1) 
which is the characteristic feature of both forms of XLCSNB has lead to the assumption 
that synaptic transmission between rod photoreceptors and ON rod bipolar cells is 
blocked. In addition, abnormalities of photopic, cone-mediated b-waves in subjects with 
CSNB2 have been identified in this study and others, suggesting an additional 
abnormality in synaptic transmission between cone photoreceptors and cone ON bipolar 
cells (Krill and Martin 1971; Miyake, Yagasaki et al. 1986). Previous studies have 
shown a reduction in peripheral s-cone sensitivity using blue on yellow perimetry and s- 
cone ERG in CSNB1; since s-cone responses are channelled only via the cone ON 
bipolar system, it follows that CSNB1 also affects the cone ON bipolar cell pathway 
(Kamiyama, Yamamoto et al. 1996; Terasaki, Miyake et al. 1999). Photopic ON-OFF 
responses, as demonstrated in this study and others, show that the cone OFF bipolar cell 
response is sub-normal in CSNB2 but normal in CSNB1; indicating an additional site of 
dysfunction in the CSNB2 group (Miyake, Yagasaki et al. 1987; Houchin, Purple et al. 
1991; Langrova, Gamer et al. 2002).
Other electrophysiological differences are apparent between the two groups. Oscillatory 
potential (OP) wavelets 1-3 are thought to represent rod and cone-mediated ON-circuitry 
responses whilst OP wavelet 4 is derived from (cone-mediated) OFF responses 
(Lachapelle, Rousseau et al. 1998; Langrova, Gamer et al. 2002). In mesopic conditions, 
this study demonstrated that the early OP wavelets derived from Standard Flash 
stimulation under mesopic conditions were absent in all subjects with CSNB1 but 
present (although abnormal in waveform) in all subjects with CSNB2. In photopic 
conditions OP are absent in subjects with CSNB2 but normal in CSNB1 subjects 
(Lachapelle, Little et al. 1983; Tremblay, Laroche et al. 1995; Langrova, Gamer et al. 
2002). The response to 30Hz frequency flicker stimulation is grossly subnormal with a 
characteristic biphasic waveform in CSNB2 but normal in amplitude in CSNB1 (Miyake, 
Horiguchi et al. 1987; Ruether, Apfelstedt-Sylla et al. 1993; Tremblay, Laroche et al.
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1995). Studies of the fast and slow rod ERG pathways show that although the slow 
pathway is blocked in CSNB1, the rod-cone-coupling (fast rod pathway) and cone OFF 
bipolar pathway still function (Scholl, Langrova et al. 2001).
In summary, these electrophysiologic characteristics suggest that CSNB1 causes a near 
total defect in transmission in the rod and cone ON retinal pathway in the presence of a 
functioning fast rod pathway and cone OFF bipolar cell pathway. CSNB2 causes a less 
severe disruption in the rod and cone ON pathway but additionally disrupts the cone OFF 
pathway, preventing efficient utilization of the fast rod pathway (see Figure 11a and b) 
(Scholl, Langrova et al. 2001; Langrova, Gamer et al. 2002).
11.5 Other electrophysiological abnormalities in XLCSNB
The photopic negative response is a relatively recently described characteristic in the 
ERG waveform thought to be derived from the activity o f retinal ganglion cells, and has 
been shown to be selectively reduced in amplitude in glaucoma and optic atrophy 
(Viswanathan, Frishman et al. 2001; Gotoh, Machida et al. 2004). This response has not 
previously been studied in XLCSNB but was found to be sub-normal in the majority of 
CSNB1 subjects and all CSNB2 subjects in our group. This suggests that there is an 
additional defect in retinal ganglion cell function in both genotypic forms.
Crossed asymmetry was demonstrated on the pattern onset VEP in two CSNB1 subjects. 
This feature has previously been regarded as diagnostic o f ocular and oculo-cutaneous 
albinism (Apkarian, Reits et al. 1983). The subjects with crossed asymmetry in this study 
did not have iris translucency but one did have tilted discs with infero-temporal 
hypopigmentation and foveal hypoplasia. A previous study has identified crossed 
asymmetry in the majority of CSNB2 subjects tested when using a flash stimulus 
(Tremblay, De Becker et al. 1996). A postulated cause for crossed asymmetry in 
XLCSNB is a disruption in the time relationship between melanogenesis and ganglion 
cell development leading to optic tract disorganization (Tremblay, De Becker et al.
1996). Since nyctalopin is thought to be involved in the establishment of neuronal 
contacts during fetal development, it is possible that its absence may play some part in 
ganglion cell misrouting in CSNB1. This issue requires further investigation and a study 
comparing the VEP in XLCSNB and ocular albinism is currently underway.
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Figure 11a: Abnormal retinal circuitry in CSNB1
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Figure 11b; Abnormal retinal circuitry in CSNB2
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11.6 Future developments
Although recent developments in electrophysiology have elucidated the defects in retinal 
circuitry caused by absence o f nyctalopin in CSNB1 and the dysfunction of the retina 
specific L-type calcium channel in CSNB2, our knowledge of the pathophysiology of 
XLCSNB is still incomplete. Although superficially similar in their basic ERG 
characteristics, CSNB1 and CSNB2 cause very distinct inner retinal abnormalities. The 
deleterious effect of calcium channel dysfunction on both the ON and OFF inner retinal 
pathways points to the central role of calcium regulation in the mediation of signal 
transmission. Molecular biological investigation of the function of nyctalopin and study 
of the nob mouse model will improve our understanding of the role of this protein during 
retinal development and its effects on the processes and pathways within the inner retina.
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Chapter 12 Summary
The clinical classification o f XLCSNB into “complete” and “incomplete” forms on the 
basis of the absence o f rod-mediated responses does not correlate with genotype. This 
study has shown that although phenotypic differences are present in subjects with 
CSNB1 (NYX  gene mutations) and CSNB2 (CACNA1F gene mutations), these 
differences are in the function of the inner retinal circuitry.
All subjects in this study, regardless of genotype, had evidence of a functioning but 
desensitized rod mediated response, although responses tended to be more severely 
depressed in CSNB1. Absence of nyctalopin severely interferes with functioning of the 
rod and cone-mediated ON inner retinal pathway. Absence of a functioning retina 
specific L-type calcium channel results in sub-normal transmission through the rod and 
cone-mediated ON inner retinal pathway and, in addition, impaired transmission through 
the cone-mediated OFF inner retinal pathway. These functional differences can be 
assessed by comparing the electrophysiological responses of the inner retina: the absence 
of scotopic oscillatory potentials in CSNB1 and the grossly sub-normal and 
characteristically biphasic appearance o f the 30Hz flicker response in CSNB2 serve as 
practical phenotypic markers which can be assessed during the basic ISCEV standard 
ERG procedure.
The finding of residual rod-mediated responses in subjects with proven NYX  gene 
mutations suggests that the current clinical classification of XLCSNB into “complete” 
and “incomplete” forms is unsatisfactory. A more suitable classification, utilizing the 
phenotypic differences in inner retinal function and their correlation with genotype, 
would be the terms CSNB1 and CSNB2, the clinical features of which are summarized in 
Table 12.
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Table12: Comparison between CSNB1 and CSNB2 (phenotype differences in bold)
CSNB1 CSNB2
Causative gene mutation NYX CACNA1F
Protein function affected Nyctalopin A1 subunit of retina specific L-type calcium 
channel
Clinical Examination
Visual acuity 
Nystagmus
Strabismus and amblyopia
High Myopia
Optic disc tilt and sectoral
hypopigmentation
Variably reduced (6/9-6/60)
Frequent
Frequent
Frequent
Frequent
Variably reduced (6/9-6/60)
Frequent
Frequent
Frequent
Frequent
Psychophysics
Colour vision 
Dark adaptation 
Scotopic perimetry
Normal
Biphasic (monphasic in some studies) 
Rod and cone threshold elevation
Normal
Biphasic
Rod and cone threshold elevation
Electrophysiology
Scotopic b-wave amplitude 
Scotopic oscillatory 
potentials
Sub-normal (absent in some studies) 
Absent
Sub-normal
Present
Photopic b-wave amplitude 
Photopic oscillatory 
potentials
30Hz flicker response 
OFF response
Normal
Present
Normal amplitude, saw tooth waveform 
Normal
Sub-normal
Absent
Grossly sub-normal, biphasic waveform 
Sub-normal
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Appendix A: Patient information sheet
CONGENITAL STATIONARY NIGHT BLINDNESS RESEARCH
INFORMA TION SHEET
Congenital Stationary Night Blindness (CSNB) is a rare, inherited visual disorder and 
little is known about its cause. By examining families affected by CSNB, we hope to 
improve our knowledge of the condition so that we may improve our understanding 
of the condition, counsel families with CSNB more effectively and possibly, in the 
future, develop new forms of therapy. We would be very grateful if you and/or other 
members of your family could help us in this research.
CSNB
The term CSNB describes a group of inherited retinal disorders that cause poor 
night vision and a degree of visual loss which remains stable throughout life. The 
commonest type is the X-linked form which only affects the males in the family, the 
gene fault may be ‘carried’ by female members of the family who may have no visual 
problems themselves but are at risk of passing the disorder on to their sons. A less 
common form may affect males or females without a family history of the condition. 
CSNB typically causes visual problems in the dark but can also reduce daytime, 
colour and distance vision and cause nystagmus (wobbly eyes). Little is known about 
the defect in the retina which causes CSNB, but we hope to improve our 
understanding of the condition by using specialised visual tests and gene studies in 
our examination of affected families.
What participating in our research would mean for you or your child:
A standard eye examination will be required which will take about 60 minutes (there 
will be a shortened examination for young children). If a blood sample has not 
already been taken at your local surgery, a small sample o f blood will be taken from 
you and/or older children. This blood sample will be used for the genetic research of 
CSNB and will not provide a personal result for you, although we will inform you of 
the advances that have been made as a result o f the study.
Some adults and older children will be asked to attend Addenbrooke’s Hospital, 
Cambridge or Moorfields Eye Hospital, London for more sophisticated tests, 
including examination of visual fields and measurement o f vision at low light levels,
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which may take several hours to complete. Although you have probably had similar 
tests performed in your own hospital, it is only by performing these tests in 
standardised manner that we can be sure to identify and compare the different forms 
of CSNB. We will provide your ophthalmologist with a detailed report of our 
findings but otherwise the results will be kept strictly confidential. Your travelling 
expenses to either centre will be reimbursed.
During the initial examination we will need to dilate your (or your child’s) pupils 
with drops. This procedure is conducted routinely in eye clinics and often causes 
temporary sensitivity to bright light and blurring of near vision. It is advisable for you 
to bring sunglasses for you or your child to wear after the examination to prevent 
dazzle and you should not drive for 5-6 hours.
We should greatly appreciate your help in our research, if you would like further 
information before deciding whether to participate, we would be very happy to 
discuss any concerns you might have. We do not expect an explanation if you decide 
against participating or if you decide to withdraw from the study at any stage, nor will 
withdrawal from the project affect your future treatment in any way.
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Appendix B: Patient Database Sheet
L E Allen
Congenital Stationary Night Blindness - History
Patient code ad 1 oo 1 a
First Name Last Name
xxxx xxxx
Age 11
Nyctalopa 0
Colour deficiency □
Comments Mother says he has always had bad vision at night
Medications Nil
POH i Myopic since 2-3 years of age
Previous Eye surgery
Nil
PMH Nil
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Congenital Stationary Night Blindness - Examination
Patient code AD 1001a
First Name
xxxx
Snellen VAR
LogMAR R
Near type BEO
IOPR
Refraction
Strabismus
Fundus Normal
6/9
N5
Transllumination □
□
□
Lens
opacity
No
Disc
abnormality
tilted discs
Last Name
Ishihara
Full
Paradoxical
pupils
□
Mollon-Reffin
T2,D1,P1
IOPL
Refraction L
Strabismus type:
Other fundal foveal hypoplasia 
abnormality
XXXX
Snellen VAL 6/9
Snellen BEO 6/9
LogMAR L
LogMAR BEO
City university test:
Nystagmus Latent
Nystagmus type:
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Appendix C: Recipes and sequencing protocols
C. 1 Buffer recipes
NEB Buffer
Tris 670mM
(Sigma Chemicals, USA)
(BDH laboratory supplies, UK)
Magnesium Chloride 1M
(Fisons Scientific UK Ltd)
T 0.1 E (lOmM Tris, O.lmM EDTA) 
pH adjusted to pH 8.8 with hydrochloric acid
P1 Buffer
Potassium chloride 2M
(Fisons Scientific UK Ltd)
Tris 1M
(Sigma Chemicals, USA)
Magnesium chloride 1M
(Fisons Scientific UK Ltd)
Gelatin 1 %
(BDH laboratory supplies, UK)
Distilled water
Sequencing Loading Buffer
Formamide 95%
(Reidel-de Haen, Germany)
Ammonium sulphate 166mM
EDTA 20mM
(Sigma Chemicals, LISA) 
Bromophenol blue 0.
(BDH laboratory supplies, UK)
05%
Xylene cyanol 0.05%
(ICN pharmaceuticals Inc. USA)
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C.2 PCR product purification
Qiaquick PCR purification kits (Qiagen Ltd. UK) were used to prepare each PCR 
exon product prior to sequencing according to the manufacturers instructions. This 
system utilises the selective binding properties of a silica-gel membrane. The binding 
buffer provided with the kit is optimised for the efficient recovery of single and 
double stranded DNA fragments from lOObp to lOkb and for the quantitiative 
(99.5%) removal o f primers under 40 bases and unincorporated nucleotides. The 
sample is drawn through the silica-gel membrane using a vacuum and DNA adsorbs 
to the silica-membrane in the presence of high salt while contaminants pass through. 
Impurities are washed away and the purified DNA fragment is eluted with Tris buffer 
(provided in kit).
C.3 Automated sequencing protocol for the ABI373 sequencer
The DNA to be sequenced was used as a single-stranded template for the synthesis of 
new DNA strands by a DNA polymerase (provided in the ABI Prism Big Dye 
Terminator Cycle Sequencing Ready Reaction Kit, PE Applied Biosystems, USA).
In addition to the normal nucleotide precursors, this DNA synthesis reaction is carried 
out in the presence of base-specific dideoxynucleotides (ddNTPs). These are analogs 
of the normal dNTPs but lack a hydroxyl group at the 3’ and 2’ carbon position. The 
ddNTP can be incorporated into the growing DNA chain but cannot participate in 
phosphodiester bonding at its 3’ carbon, resulting in abrupt termination of chain 
synthesis. The Big Dye terminators provided in the Sequencing Kit contain 
fluorophores specific for each ddNTP. During the electrophoresis run, a laser beam is 
focused at a specific constant position on the gel. As the individual DNA fragments 
migrate past this position the laser causes the dyes to fluoresce. Maximum 
fluorescence occurs at different wavelengths for the four dyes. The intensity profiles 
of each of the coloured dyes is recorded electronically and the interpreted sequence is 
stored in a computer database.
C.3.1 Sequencing Reaction
The following reagents were mixed in a labelled 0.5pi eppendorph tube:
Purified PCR product 5 pi
Specified buffer (kit) 2pl
Primer (1 Ong/pl) 1 pi
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Big Dye Terminator (last) 2jal
The thermal cycle for the sequencing reaction was: 
96E for 30 seconds 
50E for 15 seconds 
60E for 4 minutes
This was repeated 25 times. Following completion of the sequencing reaction, 
samples were stored at 4EC prior to purification.
The sequencing product was purified by the addition of:
Each sample was then mixed by vortex and placed at -20EC for 25 minutes to 
precipitate the DNA. The samples were then centrifuged at 13,000rpm for 20 minutes 
to allow a DNA pellet to form. The supernatant was carefully removed and discarded. 
The pellet was washed with 200pl o f ice-cold 75% ethanol and further centrifuged for 
2 minutes. The supematent was removed and discarded with care not to dislodge the 
DNA pellet. The samples were flash dried to remove any remaining ethanol.
C.3.2 Preparation of the sequencing gel
The sequencing plates were cleaned using water only and left to air dry. The 
following reagents were combined in a beaker and stirred:
3M sodium acetate (pH4.8) 2pi
(Fisons Scientific Equipment UK)
95% ethanol (ice cold) 
(Fisher Scientific UK)
50pl
Distilled water 
Acrylamide bis(30%) 
(Anachem Ltd. UK)
Urea
(BDH Laboratory supplies UK) 
Amberlite resin
(BDH Laboratory supplies UK)
24g
7.2ml
18.4ml
lg
10X TB E (IL )
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Tris
Boric acid
(Fisher Scientific UK) 
EDTA
108g
55g
7.44g
4.8mls of 10X TBEwas applied to the filter of a Nalgene (Nalg Nunc International 
USA) disposable filter flask and drawn through using a vacuum. The acrylamide/urea 
mixture was then added to the filter. The contents of the flask (the gel mix) were then 
left to degas for 20 minutes.
C.3.3 Pouring the gel
The clean glass sequencing plates were laid horizontally using supports, the plates 
separated by spacers. To catalyse the polmerisation of the gel, the following were 
added:
The polymerising gel mixture was then swiftly poured between the glass plates using 
a 50ml syringe. Any bubbles which had occurred during pouring were hooked out 
and the comb was introduced. The gel was allowed to polymerise for 2 hours.
C.3.4 Starting the sequencer
An initial plate check to determine the presence o f optical contamination o f the gel 
and plates was performed. If satisfactory, the upper and lower reservoirs were filled 
with IX TBE. The comb was then removed from the gel, the excess acrylamide 
rinsed from the upper gel border and the gel was then pre-run for 30 minutes at 
500mv.
C.3.5 Preparing the specim ens for loading
A formamide loading buffer was used to ensure the DNA specimens were in a single­
stranded state, (see buffer recipe C l). The pellet o f DNA formed after the purification 
procedure was resuspended in 3.5pi of formamide loading buffer and heated on the 
PCR block at 95E for 2 minutes. The samples were then put on ice prior to loading on 
the sequencing gel.
10% Ammonium persulphate 240pl
(BDH Laboratory supplies UK)
TEMED (NNN’N ’ tetramethylethylenediamine) 
(Sigma Chemicals Co USA) 26.4pl
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Appendix D: Publications derived from this 
research
Presentations
Allen LE, Moore, AT.
Congenital Stationary Night Blindness: evidence for a genotype/phenotype 
correlation. European Paediatric Ophthalmology Group, Cambridge, September 
2000 .
Allen, L.E., Bradshaw, K., Fitzke, F.W., Bird, A.C., Yates, J.R.W., Moore, A.T., 
Trump, D. Retinal function testing in X-linked CSNB can identify patients with 
mutations in the CSNB2 gene. Association fo r  Research in Vision and 
Ophthalmology. 10VS 2000 41 (4):S884
Publications
To date four publications have been accepted by peer reviewed journals from the 
research detailed in this thesis:
Zito, I., Allen, L.E., Patel, R.J., Meindl, A. Bradshaw, K., Yates, J.R. Bird, A.C. 
Erskine, L., Cheetham, M.E., Webster, A.R., Poopalasundaram, S., Moore, A.T., 
Trump, D., Hardcastle, A.J. (2003) Mutations in the CACNA1F and NYX genes in 
British CSNB families. Human Mutation. 21 (2): 169-171.
Allen, L.E., Zito, I., Bradshaw, K. Patel, R.J., Bird,A.C., Fitzke, F.W., Yates, J.R., 
Trump, D., Hardcastle, A.J., Moore, A.T. (2003) Genotype-phenotype correlation in 
British Familes with X-linked congenital stationary night blindness. British Journal 
o f Ophthalmology 87:1413-1420.
Bradshaw, K., Newman, D.K., Allen, L.E., Moore. A.T. Abnormalities of the 
scotopic threshold response correlated with gene mutation in X-linked retinoschisis 
and congenital stationary night blindness (2003). Documenta Ophthalmologica. 
107:155-164
Bradshaw, K., Allen, L.E., Trump, D., Hardcastle,A.J., George, N., Moore, A.T. A 
comparison of ERG abnormalities in X-linked retinoschisis and X-linked congenital 
stationary night blindness(2004) Documenta Ophthalmologica 108:135-145.
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Appendix E: Pedigrees
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